{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "XDPndESbX-Oz"
      },
      "source": [
        "# Python Extract Table from PDF"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ExOwvh0FYC9I",
        "outputId": "ccb7fd65-c940-4f53-b62f-42f8ae9c4511"
      },
      "execution_count": 1,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Mounted at /content/drive\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "HgmiwfwDX-O1"
      },
      "source": [
        "## With tabula-py\n",
        "\n",
        "#### Installation\n",
        "\n",
        "https://pypi.org/project/tabula-py/\n",
        "\n",
        "`pip install tabula-py`\n",
        "\n",
        "#### tabula-py docs\n",
        "\n",
        "https://www.pydoc.io/pypi/tabula-py-0.9.0/autoapi/wrapper/index.html"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "pip install tabula-py"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "QDz5hpf-YO12",
        "outputId": "62efb973-9316-4a25-9f83-59f387f6586e"
      },
      "execution_count": 3,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting tabula-py\n",
            "  Downloading tabula_py-2.10.0-py3-none-any.whl.metadata (7.6 kB)\n",
            "Requirement already satisfied: pandas>=0.25.3 in /usr/local/lib/python3.11/dist-packages (from tabula-py) (2.2.2)\n",
            "Requirement already satisfied: numpy>1.24.4 in /usr/local/lib/python3.11/dist-packages (from tabula-py) (2.0.2)\n",
            "Requirement already satisfied: distro in /usr/local/lib/python3.11/dist-packages (from tabula-py) (1.9.0)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.11/dist-packages (from pandas>=0.25.3->tabula-py) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.11/dist-packages (from pandas>=0.25.3->tabula-py) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.11/dist-packages (from pandas>=0.25.3->tabula-py) (2025.2)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.11/dist-packages (from python-dateutil>=2.8.2->pandas>=0.25.3->tabula-py) (1.17.0)\n",
            "Downloading tabula_py-2.10.0-py3-none-any.whl (12.0 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.0/12.0 MB\u001b[0m \u001b[31m88.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: tabula-py\n",
            "Successfully installed tabula-py-2.10.0\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "metadata": {
        "id": "1rSvY3O2X-O2"
      },
      "outputs": [],
      "source": [
        "from tabula import read_pdf\n",
        "from tabulate import tabulate"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "T2vcGAOMX-O3",
        "outputId": "a42228dd-686c-4c64-d9be-f0f09cb99667"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "WARNING:tabula.backend:Failed to import jpype dependencies. Fallback to subprocess.\n",
            "WARNING:tabula.backend:No module named 'jpype'\n",
            "WARNING:tabula.util:'pages' argument isn't specified.Will extract only from page 1 by default.\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[   1.000% Notes due 2022  —  The Nasdaq Stock Market LLC\n",
              " 0  1.375% Notes due 2024  —  The Nasdaq Stock Market LLC\n",
              " 1  0.000% Notes due 2025  —  The Nasdaq Stock Market LLC\n",
              " 2  0.875% Notes due 2025  —  The Nasdaq Stock Market LLC\n",
              " 3  1.625% Notes due 2026  —  The Nasdaq Stock Market LLC\n",
              " 4  2.000% Notes due 2027  —  The Nasdaq Stock Market LLC\n",
              " 5  1.375% Notes due 2029  —  The Nasdaq Stock Market LLC\n",
              " 6  3.050% Notes due 2029  —  The Nasdaq Stock Market LLC\n",
              " 7  0.500% Notes due 2031  —  The Nasdaq Stock Market LLC\n",
              " 8  3.600% Notes due 2042  —  The Nasdaq Stock Market LLC,\n",
              "                                  California  \\\n",
              " 0              (State or other jurisdiction   \n",
              " 1         of incorporation or organization)   \n",
              " 2                        One Apple Park Way   \n",
              " 3                     Cupertino, California   \n",
              " 4  (Address of principal executive offices)   \n",
              " \n",
              "                              94-2404110  \n",
              " 0  (I.R.S. Employer Identification No.)  \n",
              " 1                                   NaN  \n",
              " 2                                   NaN  \n",
              " 3                                 95014  \n",
              " 4                            (Zip Code)  ]"
            ]
          },
          "metadata": {},
          "execution_count": 5
        }
      ],
      "source": [
        "df = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\")\n",
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 12,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "m0so4GZiX-O4",
        "outputId": "b80b6c6a-3128-4a4d-b856-4a92c59d6c83"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "-  -------  -------------------------------------------------------------------------------------  --\n",
            "0  Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations  14\n",
            "1  Item 3.  Quantitative and Qualitative Disclosures About Market Risk                             19\n",
            "2  Item 4.  Controls and Procedures                                                                19\n",
            "-  -------  -------------------------------------------------------------------------------------  --\n",
            "-  --------  -----------------------------------------------------------  --\n",
            "0  Item 1A.  Risk Factors                                                 20\n",
            "1  Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds  20\n",
            "2  Item 3.   Defaults Upon Senior Securities                              21\n",
            "3  Item 4.   Mine Safety Disclosures                                      21\n",
            "4  Item 5.   Other Information                                            21\n",
            "5  Item 6.   Exhibits                                                     21\n",
            "-  --------  -----------------------------------------------------------  --\n"
          ]
        }
      ],
      "source": [
        "df_list = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", pages=3)\n",
        "for df in df_list:\n",
        "  print (tabulate(df))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 13,
      "metadata": {
        "scrolled": true,
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "q7bU3-pKX-O5",
        "outputId": "572fd15f-e11d-46c6-e448-a98cdc1e346e"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[                                      Unnamed: 0 Unnamed: 1    June 25,  \\\n",
              " 0                                            NaN        NaN        2022   \n",
              " 1                                     Net sales:        NaN         NaN   \n",
              " 2                                       Products          $      63,355   \n",
              " 3                                       Services        NaN      19,604   \n",
              " 4                                Total net sales        NaN      82,959   \n",
              " 5                                 Cost of sales:        NaN         NaN   \n",
              " 6                                       Products        NaN      41,485   \n",
              " 7                                       Services        NaN       5,589   \n",
              " 8                            Total cost of sales        NaN      47,074   \n",
              " 9                                   Gross margin        NaN      35,885   \n",
              " 10                           Operating expenses:        NaN         NaN   \n",
              " 11                      Research and development        NaN       6,797   \n",
              " 12           Selling, general and administrative        NaN       6,012   \n",
              " 13                      Total operating expenses        NaN      12,809   \n",
              " 14                              Operating income        NaN      23,076   \n",
              " 15                   Other income/(expense), net        NaN        (10)   \n",
              " 16      Income before provision for income taxes        NaN      23,066   \n",
              " 17                    Provision for income taxes        NaN       3,624   \n",
              " 18                                    Net income          $      19,442   \n",
              " 19                           Earnings per share:        NaN         NaN   \n",
              " 20                                         Basic          $        1.20   \n",
              " 21                                       Diluted          $        1.20   \n",
              " 22  Shares used in computing earnings per share:        NaN         NaN   \n",
              " 23                                         Basic        NaN  16,162,945   \n",
              " 24                                       Diluted        NaN  16,262,203   \n",
              " \n",
              "    Unnamed: 2    June 26, Unnamed: 3  June 25,.1 Unnamed: 4  June 26,.1  \n",
              " 0         NaN        2021        NaN        2022        NaN        2021  \n",
              " 1         NaN         NaN        NaN         NaN        NaN         NaN  \n",
              " 2           $      63,948          $     245,241          $     232,309  \n",
              " 3         NaN      17,486        NaN      58,941        NaN      50,148  \n",
              " 4         NaN      81,434        NaN     304,182        NaN     282,457  \n",
              " 5         NaN         NaN        NaN         NaN        NaN         NaN  \n",
              " 6         NaN      40,899        NaN     155,084        NaN     149,476  \n",
              " 7         NaN       5,280        NaN      16,411        NaN      15,319  \n",
              " 8         NaN      46,179        NaN     171,495        NaN     164,795  \n",
              " 9         NaN      35,255        NaN     132,687        NaN     117,662  \n",
              " 10        NaN         NaN        NaN         NaN        NaN         NaN  \n",
              " 11        NaN       5,717        NaN      19,490        NaN      16,142  \n",
              " 12        NaN       5,412        NaN      18,654        NaN      16,357  \n",
              " 13        NaN      11,129        NaN      38,144        NaN      32,499  \n",
              " 14        NaN      24,126        NaN      94,543        NaN      85,163  \n",
              " 15        NaN         243        NaN        (97)        NaN         796  \n",
              " 16        NaN      24,369        NaN      94,446        NaN      85,959  \n",
              " 17        NaN       2,625        NaN      15,364        NaN      11,830  \n",
              " 18          $      21,744          $      79,082          $      74,129  \n",
              " 19        NaN         NaN        NaN         NaN        NaN         NaN  \n",
              " 20          $        1.31          $        4.86          $        4.42  \n",
              " 21          $        1.30          $        4.82          $        4.38  \n",
              " 22        NaN         NaN        NaN         NaN        NaN         NaN  \n",
              " 23        NaN  16,629,371        NaN  16,277,824        NaN  16,772,656  \n",
              " 24        NaN  16,781,735        NaN  16,394,937        NaN  16,941,527  ]"
            ]
          },
          "metadata": {},
          "execution_count": 13
        }
      ],
      "source": [
        "df = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", pages=4)\n",
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 14,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "27xKKttFX-O5",
        "outputId": "d552bd61-1a3f-4477-9283-ade7216cc5e7"
      },
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[                                                    0           1    2  \\\n",
              " 0                                            Services       5,589  NaN   \n",
              " 1                                 Total cost of sales      47,074  NaN   \n",
              " 2                                        Gross margin      35,885  NaN   \n",
              " 3                                 Operating expenses:         NaN  NaN   \n",
              " 4                            Research and development       6,797  NaN   \n",
              " 5                 Selling, general and administrative       6,012  NaN   \n",
              " 6                            Total operating expenses      12,809  NaN   \n",
              " 7                                    Operating income      23,076  NaN   \n",
              " 8                         Other income/(expense), net        (10)  NaN   \n",
              " 9            Income before provision for income taxes      23,066  NaN   \n",
              " 10                         Provision for income taxes       3,624  NaN   \n",
              " 11                                       Net income $      19,442    $   \n",
              " 12                                Earnings per share:         NaN  NaN   \n",
              " 13                                            Basic $        1.20    $   \n",
              " 14                                          Diluted $        1.20    $   \n",
              " 15       Shares used in computing earnings per share:         NaN  NaN   \n",
              " 16                                              Basic  16,162,945  NaN   \n",
              " 17                                            Diluted  16,262,203  NaN   \n",
              " 18  See accompanying Notes to Condensed Consolidat...         NaN  NaN   \n",
              " 19                 Apple Inc. | Q3 2022 Form 10-Q | 1         NaN  NaN   \n",
              " \n",
              "              3   4    5           6    7           8  \n",
              " 0        5,280 NaN  NaN      16,411  NaN      15,319  \n",
              " 1       46,179 NaN  NaN     171,495  NaN     164,795  \n",
              " 2       35,255 NaN  NaN     132,687  NaN     117,662  \n",
              " 3          NaN NaN  NaN         NaN  NaN         NaN  \n",
              " 4        5,717 NaN  NaN      19,490  NaN      16,142  \n",
              " 5        5,412 NaN  NaN      18,654  NaN      16,357  \n",
              " 6       11,129 NaN  NaN      38,144  NaN      32,499  \n",
              " 7       24,126 NaN  NaN      94,543  NaN      85,163  \n",
              " 8          243 NaN  NaN        (97)  NaN         796  \n",
              " 9       24,369 NaN  NaN      94,446  NaN      85,959  \n",
              " 10       2,625 NaN  NaN      15,364  NaN      11,830  \n",
              " 11      21,744 NaN    $      79,082    $      74,129  \n",
              " 12         NaN NaN  NaN         NaN  NaN         NaN  \n",
              " 13        1.31 NaN    $        4.86    $        4.42  \n",
              " 14        1.30 NaN    $        4.82    $        4.38  \n",
              " 15         NaN NaN  NaN         NaN  NaN         NaN  \n",
              " 16  16,629,371 NaN  NaN  16,277,824  NaN  16,772,656  \n",
              " 17  16,781,735 NaN  NaN  16,394,937  NaN  16,941,527  \n",
              " 18         NaN NaN  NaN         NaN  NaN         NaN  \n",
              " 19         NaN NaN  NaN         NaN  NaN         NaN  ]"
            ]
          },
          "metadata": {},
          "execution_count": 14
        }
      ],
      "source": [
        "df = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", encoding = 'ISO-8859-1',\n",
        "         stream=True, area = [269.875, 12.75, 790.5, 961], pages = 4, guess = False,  pandas_options={'header':None})\n",
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 15,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "toLKqgW_X-O5",
        "outputId": "bab29f29-4ed6-49da-cbc0-66dd93348b54"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "WARNING:tabula.util:'pages' argument isn't specified.Will extract only from page 1 by default.\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[                                           Unnamed: 0  \\\n",
              " 0                                                 NaN   \n",
              " 1                                                 NaN   \n",
              " 2                                                 NaN   \n",
              " 3                                          (Mark One)   \n",
              " 4                                                 NaN   \n",
              " 5                                                 NaN   \n",
              " 6                                                 NaN   \n",
              " 7                                                 NaN   \n",
              " 8                                                 NaN   \n",
              " 9                                                 NaN   \n",
              " 10                                                NaN   \n",
              " 11                                                NaN   \n",
              " 12                                                NaN   \n",
              " 13                                                NaN   \n",
              " 14                                                NaN   \n",
              " 15                                                NaN   \n",
              " 16                                                NaN   \n",
              " 17                                                NaN   \n",
              " 18                                                NaN   \n",
              " 19                                                NaN   \n",
              " 20                                                NaN   \n",
              " 21                                                NaN   \n",
              " 22                                                NaN   \n",
              " 23                                                NaN   \n",
              " 24                                                NaN   \n",
              " 25                                                NaN   \n",
              " 26                                                NaN   \n",
              " 27                                                NaN   \n",
              " 28                                                NaN   \n",
              " 29                                                NaN   \n",
              " 30                                                NaN   \n",
              " 31                                                NaN   \n",
              " 32                                                NaN   \n",
              " 33  Indicate by check mark whether the Registrant ...   \n",
              " 34  months (or for such shorter period that the Re...   \n",
              " 35                                                NaN   \n",
              " 36  Indicate by check mark whether the Registrant ...   \n",
              " 37  this chapter) during the preceding 12 months (...   \n",
              " 38                                                NaN   \n",
              " 39  Indicate by check mark whether the Registrant ...   \n",
              " 40  See the definitions of âlarge accelerated fi...   \n",
              " 41                            Large accelerated filer   \n",
              " 42                              Non-accelerated filer   \n",
              " 43                                                NaN   \n",
              " \n",
              "                                         UNITED STATES  \n",
              " 0                  SECURITIES AND EXCHANGE COMMISSION  \n",
              " 1                              Washington, D.C. 20549  \n",
              " 2                                           FORM 10-Q  \n",
              " 3                                                 NaN  \n",
              " 4   â QUARTERLY REPORT PURSUANT TO SECTION 13 OR...  \n",
              " 5        For the quarterly period ended June 25, 2022  \n",
              " 6                                                  or  \n",
              " 7   â TRANSITION REPORT PURSUANT TO SECTION 13 O...  \n",
              " 8                   For the transition period fromto.  \n",
              " 9                   Commission File Number: 001-36743  \n",
              " 10                                         Apple Inc.  \n",
              " 11  (Exact name of Registrant as specified in its ...  \n",
              " 12                              California 94-2404110  \n",
              " 13  (State or other jurisdiction (I.R.S. Employer ...  \n",
              " 14                  of incorporation or organization)  \n",
              " 15                                 One Apple Park Way  \n",
              " 16                        Cupertino, California 95014  \n",
              " 17  (Address of principal executive offices) (Zip ...  \n",
              " 18                                     (408) 996-1010  \n",
              " 19  (Registrantâs telephone number, including ar...  \n",
              " 20  Securities registered pursuant to Section 12(b...  \n",
              " 21  Title of each class Trading symbol(s) Name of ...  \n",
              " 22  Common Stock, $0.00001 par value per share AAP...  \n",
              " 23  1.000% Notes due 2022 â The Nasdaq Stock Mar...  \n",
              " 24  1.375% Notes due 2024 â The Nasdaq Stock Mar...  \n",
              " 25  0.000% Notes due 2025 â The Nasdaq Stock Mar...  \n",
              " 26  0.875% Notes due 2025 â The Nasdaq Stock Mar...  \n",
              " 27  1.625% Notes due 2026 â The Nasdaq Stock Mar...  \n",
              " 28  2.000% Notes due 2027 â The Nasdaq Stock Mar...  \n",
              " 29  1.375% Notes due 2029 â The Nasdaq Stock Mar...  \n",
              " 30  3.050% Notes due 2029 â The Nasdaq Stock Mar...  \n",
              " 31  0.500% Notes due 2031 â The Nasdaq Stock Mar...  \n",
              " 32  3.600% Notes due 2042 â The Nasdaq Stock Mar...  \n",
              " 33                                                NaN  \n",
              " 34                                                NaN  \n",
              " 35                                    Yes  âNo  â  \n",
              " 36                                                NaN  \n",
              " 37                                                NaN  \n",
              " 38                                    Yes  âNo  â  \n",
              " 39                                                NaN  \n",
              " 40                                                NaN  \n",
              " 41                          â Accelerated filer â  \n",
              " 42                  â Smaller reporting company â  \n",
              " 43                        Emerging growth company â  ]"
            ]
          },
          "metadata": {},
          "execution_count": 15
        }
      ],
      "source": [
        "df = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", encoding = 'ISO-8859-1',\n",
        "         stream=True, guess = False)\n",
        "df"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 16,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ssYC_N2UX-O5",
        "outputId": "f317d950-3b3b-48ca-c794-f9de1384250d"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "WARNING:tabula.util:'pages' argument isn't specified.Will extract only from page 1 by default.\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "[                                           Unnamed: 0  \\\n",
              " 0                                                 NaN   \n",
              " 1                                          California   \n",
              " 2                        (State or other jurisdiction   \n",
              " 3                   of incorporation or organization)   \n",
              " 4                                  One Apple Park Way   \n",
              " 5                               Cupertino, California   \n",
              " 6            (Address of principal executive offices)   \n",
              " 7                                                 NaN   \n",
              " 8                                                 NaN   \n",
              " 9                                                 NaN   \n",
              " 10                                Title of each class   \n",
              " 11         Common Stock, $0.00001 par value per share   \n",
              " 12                              1.000% Notes due 2022   \n",
              " 13                              1.375% Notes due 2024   \n",
              " 14                              0.000% Notes due 2025   \n",
              " 15                              0.875% Notes due 2025   \n",
              " 16                              1.625% Notes due 2026   \n",
              " 17                              2.000% Notes due 2027   \n",
              " 18                              1.375% Notes due 2029   \n",
              " 19                              3.050% Notes due 2029   \n",
              " 20                              0.500% Notes due 2031   \n",
              " 21                              3.600% Notes due 2042   \n",
              " 22  Indicate by check mark whether the Registrant ...   \n",
              " 23  months (or for such shorter period that the Re...   \n",
              " 24                                                NaN   \n",
              " 25  Indicate by check mark whether the Registrant ...   \n",
              " 26  this chapter) during the preceding 12 months (...   \n",
              " 27                                                NaN   \n",
              " 28  Indicate by check mark whether the Registrant ...   \n",
              " 29  See the definitions of âlarge accelerated fi...   \n",
              " 30                        Large accelerated filer â   \n",
              " 31                          Non-accelerated filer â   \n",
              " 32                                                NaN   \n",
              " \n",
              "                                            Apple Inc. Unnamed: 1  \n",
              " 0   (Exact name of Registrant as specified in its ...        NaN  \n",
              " 1                                          94-2404110        NaN  \n",
              " 2                (I.R.S. Employer Identification No.)        NaN  \n",
              " 3                                                 NaN        NaN  \n",
              " 4                                                 NaN        NaN  \n",
              " 5                                               95014        NaN  \n",
              " 6                                          (Zip Code)        NaN  \n",
              " 7                                      (408) 996-1010        NaN  \n",
              " 8   (Registrantâs telephone number, including ar...        NaN  \n",
              " 9   Securities registered pursuant to Section 12(b...        NaN  \n",
              " 10  Trading symbol(s) Name of each exchange on whi...        NaN  \n",
              " 11                   AAPL The Nasdaq Stock Market LLC        NaN  \n",
              " 12                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 13                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 14                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 15                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 16                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 17                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 18                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 19                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 20                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 21                    â The Nasdaq Stock Market LLC        NaN  \n",
              " 22                                                NaN        NaN  \n",
              " 23                                                NaN        NaN  \n",
              " 24                                    Yes  âNo  â        NaN  \n",
              " 25                                                NaN        NaN  \n",
              " 26                                                NaN        NaN  \n",
              " 27                                    Yes  âNo  â        NaN  \n",
              " 28                                                NaN        NaN  \n",
              " 29                                                NaN        NaN  \n",
              " 30                                  Accelerated filer        â  \n",
              " 31                          Smaller reporting company        â  \n",
              " 32                            Emerging growth company        â  ]"
            ]
          },
          "metadata": {},
          "execution_count": 16
        }
      ],
      "source": [
        "df = read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", encoding = 'ISO-8859-1',\n",
        "         stream=True, area=[269.875, 12.75, 790.5, 961], guess = False)\n",
        "df"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "LR6EAnj5X-O6"
      },
      "source": [
        "## With Camelot\n",
        "\n",
        "#### Installation\n",
        "\n",
        "https://pypi.org/project/camelot-py/\n",
        "\n",
        "`pip install camelot-py`\n",
        "\n",
        "#### Camelot readme\n",
        "\n",
        "https://github.com/socialcopsdev/camelot"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "pip install camelot-py"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "gLB9p6lZaScV",
        "outputId": "5845ad5e-64ae-4337-ace9-8b7d67b26eff"
      },
      "execution_count": 18,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting camelot-py\n",
            "  Downloading camelot_py-1.0.0-py3-none-any.whl.metadata (9.4 kB)\n",
            "Requirement already satisfied: click>=8.0.1 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (8.2.1)\n",
            "Requirement already satisfied: chardet>=5.1.0 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (5.2.0)\n",
            "Requirement already satisfied: numpy>=1.24.4 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (2.0.2)\n",
            "Requirement already satisfied: openpyxl>=3.1.0 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (3.1.5)\n",
            "Collecting pdfminer-six>=20240706 (from camelot-py)\n",
            "  Downloading pdfminer_six-20250506-py3-none-any.whl.metadata (4.2 kB)\n",
            "Collecting pypdf<4.0,>=3.17 (from camelot-py)\n",
            "  Downloading pypdf-3.17.4-py3-none-any.whl.metadata (7.5 kB)\n",
            "Requirement already satisfied: pandas>=2.2.2 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (2.2.2)\n",
            "Requirement already satisfied: tabulate>=0.9.0 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (0.9.0)\n",
            "Requirement already satisfied: opencv-python-headless>=4.7.0.68 in /usr/local/lib/python3.11/dist-packages (from camelot-py) (4.12.0.88)\n",
            "Collecting pypdfium2>=4 (from camelot-py)\n",
            "  Downloading pypdfium2-4.30.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (48 kB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m48.5/48.5 kB\u001b[0m \u001b[31m1.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: et-xmlfile in /usr/local/lib/python3.11/dist-packages (from openpyxl>=3.1.0->camelot-py) (2.0.0)\n",
            "Requirement already satisfied: python-dateutil>=2.8.2 in /usr/local/lib/python3.11/dist-packages (from pandas>=2.2.2->camelot-py) (2.9.0.post0)\n",
            "Requirement already satisfied: pytz>=2020.1 in /usr/local/lib/python3.11/dist-packages (from pandas>=2.2.2->camelot-py) (2025.2)\n",
            "Requirement already satisfied: tzdata>=2022.7 in /usr/local/lib/python3.11/dist-packages (from pandas>=2.2.2->camelot-py) (2025.2)\n",
            "Requirement already satisfied: charset-normalizer>=2.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer-six>=20240706->camelot-py) (3.4.2)\n",
            "Requirement already satisfied: cryptography>=36.0.0 in /usr/local/lib/python3.11/dist-packages (from pdfminer-six>=20240706->camelot-py) (43.0.3)\n",
            "Requirement already satisfied: cffi>=1.12 in /usr/local/lib/python3.11/dist-packages (from cryptography>=36.0.0->pdfminer-six>=20240706->camelot-py) (1.17.1)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.11/dist-packages (from python-dateutil>=2.8.2->pandas>=2.2.2->camelot-py) (1.17.0)\n",
            "Requirement already satisfied: pycparser in /usr/local/lib/python3.11/dist-packages (from cffi>=1.12->cryptography>=36.0.0->pdfminer-six>=20240706->camelot-py) (2.22)\n",
            "Downloading camelot_py-1.0.0-py3-none-any.whl (66 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m66.6/66.6 kB\u001b[0m \u001b[31m3.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pdfminer_six-20250506-py3-none-any.whl (5.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m5.6/5.6 MB\u001b[0m \u001b[31m59.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdf-3.17.4-py3-none-any.whl (278 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m278.2/278.2 kB\u001b[0m \u001b[31m20.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pypdfium2-4.30.0-py3-none-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (2.8 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m2.8/2.8 MB\u001b[0m \u001b[31m76.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pypdfium2, pypdf, pdfminer-six, camelot-py\n",
            "Successfully installed camelot-py-1.0.0 pdfminer-six-20250506 pypdf-3.17.4 pypdfium2-4.30.0\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 23,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "To8Kc0aDX-O6",
        "outputId": "40ee320c-eb0c-4245-97b8-9c48e3b9d418"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "No tables found on this page.\n"
          ]
        }
      ],
      "source": [
        "import camelot\n",
        "tables = camelot.read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\")\n",
        "if tables:\n",
        "  print(tables[0].df[1:3])\n",
        "else:\n",
        "  print(\"No tables found on this page.\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 38,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "BK69ouiKX-O7",
        "outputId": "3068f832-49f3-4149-d0c8-cdd0444a3b01"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "No tables found on page 4.\n"
          ]
        }
      ],
      "source": [
        "tables1 = camelot.read_pdf(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\", pages='4') #area=[269.875, 120.75, 790.5, 561]\n",
        "if tables1:\n",
        "    print(tabulate(tables1[0].df))\n",
        "else:\n",
        "    print(\"No tables found on page 4.\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 45,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qbANKTbVX-O7",
        "outputId": "4a507be5-a380-4ec8-a73d-f32648498075"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 533.9085243932078, 528.9866103458384, 759.6974764882635)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (0, 0, 612.0, 792.0)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 532.5585621774561, 603.9987381761364, 698.4862809784219)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 620.9831944610959, 604.0000130484927, 737.0479759534727)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 154.5585467274576, 604.0000150059924, 759.1231747792622)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 520.4085975317047, 603.9960578189388, 752.9580007730766)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n",
            "/usr/local/lib/python3.11/dist-packages/camelot/parsers/base.py:238: UserWarning: No tables found in table area (8.224997320625082, 611.5335955588306, 603.9985302086596, 754.508580562206)\n",
            "  cols, rows, v_s, h_s = self._generate_columns_and_rows(bbox, user_cols)\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Table 1:\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   0 |            | UNITED STATES                                                                              |\n",
            "+=====+============+============================================================================================+\n",
            "|   1 |            | SECURITIES AND EXCHANGE COMMISSION                                                         |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   2 |            | Washington, D.C. 20549                                                                     |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   3 |            | FORM 10-Q                                                                                  |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   4 | (Mark One) |                                                                                            |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   5 |            | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   6 |            | For the quarterly period ended June 25, 2022                                               |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   7 |            | or                                                                                         |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   8 |            | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|   9 |            | For the transition period from              to             .                               |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "|  10 |            | Commission File Number: 001-36743                                                          |\n",
            "+-----+------------+--------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 2:\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   0 |                                          | Apple Inc.                                             |                                      |\n",
            "+=====+==========================================+========================================================+======================================+\n",
            "|   1 |                                          | (Exact name of Registrant as specified in its charter) |                                      |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   2 | California                               |                                                        | 94-2404110                           |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   3 | (State or other jurisdiction             |                                                        | (I.R.S. Employer Identification No.) |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   4 | of incorporation or organization)        |                                                        |                                      |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   5 | One Apple Park Way                       |                                                        |                                      |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   6 | Cupertino, California                    |                                                        | 95014                                |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "|   7 | (Address of principal executive offices) |                                                        | (Zip Code)                           |\n",
            "+-----+------------------------------------------+--------------------------------------------------------+--------------------------------------+\n",
            "\n",
            "\n",
            "Table 3:\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   0 |                                            | (Registrant’s telephone number, including area code)        |                                           |\n",
            "+=====+============================================+=============================================================+===========================================+\n",
            "|   1 |                                            | Securities registered pursuant to Section 12(b) of the Act: |                                           |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   2 | Title of each class                        | Trading symbol(s)                                           | Name of each exchange on which registered |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   3 | Common Stock, $0.00001 par value per share | AAPL                                                        | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   4 | 1.000% Notes due 2022                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   5 | 1.375% Notes due 2024                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   6 | 0.000% Notes due 2025                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   7 | 0.875% Notes due 2025                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   8 | 1.625% Notes due 2026                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|   9 | 2.000% Notes due 2027                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|  10 | 1.375% Notes due 2029                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|  11 | 3.050% Notes due 2029                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|  12 | 0.500% Notes due 2031                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "|  13 | 3.600% Notes due 2042                      | —                                                           | The Nasdaq Stock Market LLC               |\n",
            "+-----+--------------------------------------------+-------------------------------------------------------------+-------------------------------------------+\n",
            "\n",
            "\n",
            "Table 4:\n",
            "+-----+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | If  an  emerging  growth  company,  indicate  by  check  mark  if  the  Registrant  has  elected  not  to  use  the  extended  transition  period  for  complying  with  any  new  or  revised  financial   |\n",
            "+=====+=============================================================================================================================================================================================================+\n",
            "|   1 | accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐                                                                                                                              |\n",
            "+-----+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).                                                                                            |\n",
            "+-----+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | Yes  ☐     No  ☒                                                                                                                                                                                            |\n",
            "+-----+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | 16,070,752,000 shares of common stock were issued and outstanding as of July 15, 2022.                                                                                                                      |\n",
            "+-----+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 5:\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   0 |          |                                                                                       | Page   |\n",
            "+=====+==========+=======================================================================================+========+\n",
            "|   1 |          | Part I                                                                                |        |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   2 | Item 1.  | Financial Statements                                                                  | 1      |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   3 | Item 2.  | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 14     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   4 | Item 3.  | Quantitative and Qualitative Disclosures About Market Risk                            | 19     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   5 | Item 4.  | Controls and Procedures                                                               | 19     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   6 |          | Part II                                                                               |        |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   7 | Item 1.  | Legal Proceedings                                                                     | 20     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   8 | Item 1A. | Risk Factors                                                                          | 20     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|   9 | Item 2.  | Unregistered Sales of Equity Securities and Use of Proceeds                           | 20     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|  10 | Item 3.  | Defaults Upon Senior Securities                                                       | 21     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|  11 | Item 4.  | Mine Safety Disclosures                                                               | 21     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|  12 | Item 5.  | Other Information                                                                     | 21     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "|  13 | Item 6.  | Exhibits                                                                              | 21     |\n",
            "+-----+----------+---------------------------------------------------------------------------------------+--------+\n",
            "\n",
            "\n",
            "Table 6:\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   0 |                                              |    |            | Three Months Ended   |            |    |            | Nine Months Ended   |            |\n",
            "+=====+==============================================+====+============+======================+============+====+============+=====================+============+\n",
            "|   1 |                                              |    | June 25,   |                      | June 26,   |    | June 25,   |                     | June 26,   |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   2 |                                              |    | 2022       |                      | 2021       |    | 2022       |                     | 2021       |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   3 | Net sales:                                   |    |            |                      |            |    |            |                     |            |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   4 | Products                                     | $  | 63,355     | $                    | 63,948     | $  | 245,241    | $                   | 232,309    |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   5 | Services                                     |    | 19,604     |                      | 17,486     |    | 58,941     |                     | 50,148     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   6 | Total net sales                              |    | 82,959     |                      | 81,434     |    | 304,182    |                     | 282,457    |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   7 | Cost of sales:                               |    |            |                      |            |    |            |                     |            |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   8 | Products                                     |    | 41,485     |                      | 40,899     |    | 155,084    |                     | 149,476    |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   9 | Services                                     |    | 5,589      |                      | 5,280      |    | 16,411     |                     | 15,319     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  10 | Total cost of sales                          |    | 47,074     |                      | 46,179     |    | 171,495    |                     | 164,795    |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  11 | Gross margin                                 |    | 35,885     |                      | 35,255     |    | 132,687    |                     | 117,662    |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  12 | Operating expenses:                          |    |            |                      |            |    |            |                     |            |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  13 | Research and development                     |    | 6,797      |                      | 5,717      |    | 19,490     |                     | 16,142     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  14 | Selling, general and administrative          |    | 6,012      |                      | 5,412      |    | 18,654     |                     | 16,357     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  15 | Total operating expenses                     |    | 12,809     |                      | 11,129     |    | 38,144     |                     | 32,499     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  16 | Operating income                             |    | 23,076     |                      | 24,126     |    | 94,543     |                     | 85,163     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  17 | Other income/(expense), net                  |    | (10)       |                      | 243        |    | (97)       |                     | 796        |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  18 | Income before provision for income taxes     |    | 23,066     |                      | 24,369     |    | 94,446     |                     | 85,959     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  19 | Provision for income taxes                   |    | 3,624      |                      | 2,625      |    | 15,364     |                     | 11,830     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  20 | Net income                                   | $  | 19,442     | $                    | 21,744     | $  | 79,082     | $                   | 74,129     |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  21 | Earnings per share:                          |    |            |                      |            |    |            |                     |            |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  22 | Basic                                        | $  | 1.20       | $                    | 1.31       | $  | 4.86       | $                   | 4.42       |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  23 | Diluted                                      | $  | 1.20       | $                    | 1.30       | $  | 4.82       | $                   | 4.38       |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  24 | Shares used in computing earnings per share: |    |            |                      |            |    |            |                     |            |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  25 | Basic                                        |    | 16,162,945 |                      | 16,629,371 |    | 16,277,824 |                     | 16,772,656 |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  26 | Diluted                                      |    | 16,262,203 |                      | 16,781,735 |    | 16,394,937 |                     | 16,941,527 |\n",
            "+-----+----------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "\n",
            "\n",
            "Table 7:\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   0 |                                                                              |    |          | Three Months Ended   |          |    |          | Nine Months Ended   |          |\n",
            "+=====+==============================================================================+====+==========+======================+==========+====+==========+=====================+==========+\n",
            "|   1 |                                                                              |    | June 25, |                      | June 26, |    | June 25, |                     | June 26, |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   2 |                                                                              |    | 2022     |                      | 2021     |    | 2022     |                     | 2021     |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   3 | Net income                                                                   | $  | 19,442   | $                    | 21,744   | $  | 79,082   | $                   | 74,129   |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   4 | Other comprehensive income/(loss):                                           |    |          |                      |          |    |          |                     |          |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   5 | Change in foreign currency translation, net of tax                           |    | (721)    |                      | 188      |    | (1,102)  |                     | 659      |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   6 | Change in unrealized gains/losses on derivative instruments, net of tax:     |    |          |                      |          |    |          |                     |          |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   7 | Change in fair value of derivative instruments                               |    | 852      |                      | (24)     |    | 1,548    |                     | 4        |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   8 | Adjustment for net (gains)/losses realized and included in net income        |    | 121      |                      | 17       |    | (87)     |                     | 593      |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   9 | Total change in unrealized gains/losses on derivative instruments            |    | 973      |                      | (7)      |    | 1,461    |                     | 597      |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  10 | Change in unrealized gains/losses on marketable debt securities, net of tax: |    |          |                      |          |    |          |                     |          |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  11 | Change in fair value of marketable debt securities                           |    | (3,150)  |                      | 217      |    | (9,959)  |                     | (558)    |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  12 | Adjustment for net (gains)/losses realized and included in net income        |    | 95       |                      | (54)     |    | 140      |                     | (234)    |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  13 | Total change in unrealized gains/losses on marketable debt                   |    |          |                      |          |    |          |                     |          |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  14 | securities                                                                   |    | (3,055)  |                      | 163      |    | (9,819)  |                     | (792)    |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  15 | Total other comprehensive income/(loss)                                      |    | (2,803)  |                      | 344      |    | (9,460)  |                     | 464      |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  16 | Total comprehensive income                                                   | $  | 16,639   | $                    | 22,088   | $  | 69,622   | $                   | 74,593   |\n",
            "+-----+------------------------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "\n",
            "\n",
            "Table 8:\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   0 |                                    |                                       | June 25,   |    | September 25,   |\n",
            "+=====+====================================+=======================================+============+====+=================+\n",
            "|   1 |                                    |                                       | 2022       |    | 2021            |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   2 |                                    | ASSETS:                               |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   3 | Current assets:                    |                                       |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   4 | Cash and cash equivalents          | $                                     | 27,502     | $  | 34,940          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   5 | Marketable securities              |                                       | 20,729     |    | 27,699          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   6 | Accounts receivable, net           |                                       | 21,803     |    | 26,278          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   7 | Inventories                        |                                       | 5,433      |    | 6,580           |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   8 | Vendor non-trade receivables       |                                       | 20,439     |    | 25,228          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|   9 | Other current assets               |                                       | 16,386     |    | 14,111          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  10 | Total current assets               |                                       | 112,292    |    | 134,836         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  11 | Non-current assets:                |                                       |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  12 | Marketable securities              |                                       | 131,077    |    | 127,877         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  13 | Property, plant and equipment, net |                                       | 40,335     |    | 39,440          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  14 | Other non-current assets           |                                       | 52,605     |    | 48,849          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  15 | Total non-current assets           |                                       | 224,017    |    | 216,166         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  16 | Total assets                       | $                                     | 336,309    | $  | 351,002         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  17 |                                    | LIABILITIES AND SHAREHOLDERS’ EQUITY: |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  18 | Current liabilities:               |                                       |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  19 | Accounts payable                   | $                                     | 48,343     | $  | 54,763          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  20 | Other current liabilities          |                                       | 48,811     |    | 47,493          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  21 | Deferred revenue                   |                                       | 7,728      |    | 7,612           |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  22 | Commercial paper                   |                                       | 10,982     |    | 6,000           |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  23 | Term debt                          |                                       | 14,009     |    | 9,613           |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  24 | Total current liabilities          |                                       | 129,873    |    | 125,481         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  25 | Non-current liabilities:           |                                       |            |    |                 |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  26 | Term debt                          |                                       | 94,700     |    | 109,106         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  27 | Other non-current liabilities      |                                       | 53,629     |    | 53,325          |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  28 | Total non-current liabilities      |                                       | 148,329    |    | 162,431         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "|  29 | Total liabilities                  |                                       | 278,202    |    | 287,912         |\n",
            "+-----+------------------------------------+---------------------------------------+------------+----+-----------------+\n",
            "\n",
            "\n",
            "Table 9:\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   0 |                                                                 |    |          | Three Months Ended   |          |    |          | Nine Months Ended   |          |\n",
            "+=====+=================================================================+====+==========+======================+==========+====+==========+=====================+==========+\n",
            "|   1 |                                                                 |    | June 25, |                      | June 26, |    | June 25, |                     | June 26, |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   2 |                                                                 |    | 2022     |                      | 2021     |    | 2022     |                     | 2021     |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   3 | Total shareholders’ equity, beginning balances                  | $  | 67,399   | $                    | 69,178   | $  | 63,090   | $                   | 65,339   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   4 | Common stock and additional paid-in capital:                    |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   5 | Beginning balances                                              |    | 61,181   |                      | 54,203   |    | 57,365   |                     | 50,779   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   6 | Common stock issued                                             |    | —        |                      | —        |    | 593      |                     | 561      |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   7 | Common stock withheld related to net share settlement of equity |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   8 | awards                                                          |    | (1,371)  |                      | (1,224)  |    | (2,783)  |                     | (2,460)  |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   9 | Share-based compensation                                        |    | 2,305    |                      | 2,010    |    | 6,940    |                     | 6,109    |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  10 | Ending balances                                                 |    | 62,115   |                      | 54,989   |    | 62,115   |                     | 54,989   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  11 | Retained earnings:                                              |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  12 | Beginning balances                                              |    | 12,712   |                      | 15,261   |    | 5,562    |                     | 14,966   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  13 | Net income                                                      |    | 19,442   |                      | 21,744   |    | 79,082   |                     | 74,129   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  14 | Dividends and dividend equivalents declared                     |    | (3,760)  |                      | (3,713)  |    | (11,058) |                     | (10,755) |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  15 | Common stock withheld related to net share settlement of equity |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  16 | awards                                                          |    | (1,403)  |                      | (1,559)  |    | (3,323)  |                     | (3,606)  |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  17 | Common stock repurchased                                        |    | (21,702) |                      | (22,500) |    | (64,974) |                     | (65,501) |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  18 | Ending balances                                                 |    | 5,289    |                      | 9,233    |    | 5,289    |                     | 9,233    |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  19 | Accumulated other comprehensive income/(loss):                  |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  20 | Beginning balances                                              |    | (6,494)  |                      | (286)    |    | 163      |                     | (406)    |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  21 | Other comprehensive income/(loss)                               |    | (2,803)  |                      | 344      |    | (9,460)  |                     | 464      |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  22 | Ending balances                                                 |    | (9,297)  |                      | 58       |    | (9,297)  |                     | 58       |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  23 | Total shareholders’ equity, ending balances                     | $  | 58,107   | $                    | 64,280   | $  | 58,107   | $                   | 64,280   |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  24 | Dividends and dividend equivalents declared per share or RSU    | $  | 0.23     | $                    | 0.22     | $  | 0.67     | $                   | 0.63     |\n",
            "+-----+-----------------------------------------------------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "\n",
            "\n",
            "Table 10:\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   0 |                                                                                |    |          | Nine Months Ended   |          |\n",
            "+=====+================================================================================+====+==========+=====================+==========+\n",
            "|   1 |                                                                                |    | June 25, |                     | June 26, |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   2 |                                                                                |    | 2022     |                     | 2021     |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   3 | Cash, cash equivalents and restricted cash, beginning balances                 | $  | 35,929   | $                   | 39,789   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   4 | Operating activities:                                                          |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   5 | Net income                                                                     |    | 79,082   |                     | 74,129   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   6 | Adjustments to reconcile net income to cash generated by operating activities: |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   7 | Depreciation and amortization                                                  |    | 8,239    |                     | 8,295    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   8 | Share-based compensation expense                                               |    | 6,760    |                     | 5,961    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|   9 | Deferred income tax expense/(benefit)                                          |    | 2,756    |                     | (737)    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  10 | Other                                                                          |    | (61)     |                     | (689)    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  11 | Changes in operating assets and liabilities:                                   |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  12 | Accounts receivable, net                                                       |    | 4,561    |                     | (1,316)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  13 | Inventories                                                                    |    | 1,049    |                     | (1,213)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  14 | Vendor non-trade receivables                                                   |    | 4,789    |                     | 4,892    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  15 | Other current and non-current assets                                           |    | (3,289)  |                     | (5,899)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  16 | Accounts payable                                                               |    | (6,108)  |                     | (1,786)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  17 | Deferred revenue                                                               |    | 260      |                     | 1,738    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  18 | Other current and non-current liabilities                                      |    | (14)     |                     | 463      |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  19 | Cash generated by operating activities                                         |    | 98,024   |                     | 83,838   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  20 | Investing activities:                                                          |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  21 | Purchases of marketable securities                                             |    | (70,178) |                     | (94,052) |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  22 | Proceeds from maturities of marketable securities                              |    | 24,203   |                     | 49,880   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  23 | Proceeds from sales of marketable securities                                   |    | 33,609   |                     | 36,745   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  24 | Payments for acquisition of property, plant and equipment                      |    | (7,419)  |                     | (7,862)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  25 | Payments made in connection with business acquisitions, net                    |    | (169)    |                     | (13)     |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  26 | Other                                                                          |    | (1,183)  |                     | (78)     |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  27 | Cash used in investing activities                                              |    | (21,137) |                     | (15,380) |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  28 | Financing activities:                                                          |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  29 | Payments for taxes related to net share settlement of equity awards            |    | (5,915)  |                     | (5,855)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  30 | Payments for dividends and dividend equivalents                                |    | (11,138) |                     | (10,827) |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  31 | Repurchases of common stock                                                    |    | (64,974) |                     | (66,223) |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  32 | Proceeds from issuance of term debt, net                                       |    | —        |                     | 13,923   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  33 | Repayments of term debt                                                        |    | (6,750)  |                     | (7,500)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  34 | Proceeds from commercial paper, net                                            |    | 4,970    |                     | 3,022    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  35 | Other                                                                          |    | (148)    |                     | 489      |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  36 | Cash used in financing activities                                              |    | (83,955) |                     | (72,971) |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  37 | Decrease in cash, cash equivalents and restricted cash                         |    | (7,068)  |                     | (4,513)  |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  38 | Cash, cash equivalents and restricted cash, ending balances                    | $  | 28,861   | $                   | 35,276   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  39 | Supplemental cash flow disclosure:                                             |    |          |                     |          |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  40 | Cash paid for income taxes, net                                                | $  | 12,251   | $                   | 18,536   |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "|  41 | Cash paid for interest                                                         | $  | 1,910    | $                   | 1,870    |\n",
            "+-----+--------------------------------------------------------------------------------+----+----------+---------------------+----------+\n",
            "\n",
            "\n",
            "Table 11:\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | Note 1 – Summary of Significant Accounting Policies                                                                                                                              |\n",
            "+=====+==================================================================================================================================================================================+\n",
            "|   1 | Basis of Presentation and Preparation                                                                                                                                            |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”).                    |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements                         |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | reflect  all  adjustments,  which  are  normal  and  recurring  in  nature,  necessary  for  fair  financial  statement  presentation.  The  preparation  of  these  condensed   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 | consolidated  financial  statements  and  accompanying  notes  in  conformity  with  U.S.  generally  accepted  accounting  principles  requires  management  to  make           |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | estimates  and  assumptions  that  affect  the  amounts  reported. Actual  results  could  differ  materially  from  those  estimates.  Certain  prior  period  amounts  in  the |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed                       |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | consolidated  financial  statements  and  accompanying  notes  should  be  read  in  conjunction  with  the  Company’s  annual  consolidated  financial  statements  and         |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 25, 2021.                                                                      |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 | The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. An additional week is included in the first fiscal quarter                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2022 and 2021 span 52 weeks each. Unless                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  12 | otherwise  stated,  references  to  particular  years,  quarters,  months  and  periods  refer  to  the  Company’s  fiscal  years  ended  in  September  and  the  associated    |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  13 | quarters, months and periods of those fiscal years.                                                                                                                              |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 12:\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   0 |                                           |    |            | Three Months Ended   |            |    |            | Nine Months Ended   |            |\n",
            "+=====+===========================================+====+============+======================+============+====+============+=====================+============+\n",
            "|   1 |                                           |    | June 25,   |                      | June 26,   |    | June 25,   |                     | June 26,   |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   2 |                                           |    | 2022       |                      | 2021       |    | 2022       |                     | 2021       |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   3 | Numerator:                                |    |            |                      |            |    |            |                     |            |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   4 | Net income                                | $  | 19,442     | $                    | 21,744     | $  | 79,082     | $                   | 74,129     |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   5 | Denominator:                              |    |            |                      |            |    |            |                     |            |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   6 | Weighted-average basic shares outstanding |    | 16,162,945 |                      | 16,629,371 |    | 16,277,824 |                     | 16,772,656 |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   7 | Effect of dilutive securities             |    | 99,258     |                      | 152,364    |    | 117,113    |                     | 168,871    |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   8 | Weighted-average diluted shares           |    | 16,262,203 |                      | 16,781,735 |    | 16,394,937 |                     | 16,941,527 |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|   9 | Basic earnings per share                  | $  | 1.20       | $                    | 1.31       | $  | 4.86       | $                   | 4.42       |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "|  10 | Diluted earnings per share                | $  | 1.20       | $                    | 1.30       | $  | 4.82       | $                   | 4.38       |\n",
            "+-----+-------------------------------------------+----+------------+----------------------+------------+----+------------+---------------------+------------+\n",
            "\n",
            "\n",
            "Table 13:\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   0 | millions):                      |    |          |                    |          |    |          |                   |          |\n",
            "+=====+=================================+====+==========+====================+==========+====+==========+===================+==========+\n",
            "|   1 |                                 |    |          | Three Months Ended |          |    |          | Nine Months Ended |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   2 |                                 |    | June 25, |                    | June 26, |    | June 25, |                   | June 26, |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   3 |                                 |    | 2022     |                    | 2021     |    | 2022     |                   | 2021     |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   4 | ® (1)                           |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   5 | iPhone                          | $  | 40,665   | $                  | 39,570   | $  | 162,863  | $                 | 153,105  |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   6 | ® (1)                           |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   7 | Mac                             |    | 7,382    |                    | 8,235    |    | 28,669   |                   | 26,012   |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   8 | ® (1)                           |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|   9 | iPad                            |    | 7,224    |                    | 7,368    |    | 22,118   |                   | 23,610   |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  10 | (1)(2)                          |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  11 | Wearables, Home and Accessories |    | 8,084    |                    | 8,775    |    | 31,591   |                   | 29,582   |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  12 |                                 |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  13 | (3)                             |    | 19,604   |                    | 17,486   |    | 58,941   |                   | 50,148   |\n",
            "|     | Services                        |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  14 | (4)                             | $  | 82,959   | $                  | 81,434   | $  | 304,182  | $                 | 282,457  |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "|  15 | Total net sales                 |    |          |                    |          |    |          |                   |          |\n",
            "+-----+---------------------------------+----+----------+--------------------+----------+----+----------+-------------------+----------+\n",
            "\n",
            "\n",
            "Table 14:\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 |                 |                                                                                                                                                                                     |\n",
            "+=====+=================+=====================================================================================================================================================================================+\n",
            "|   1 | Services        | (3)                                                                                                                                                                                 |\n",
            "|     |                 | 19,604                                                                                                                                                                              |\n",
            "|     |                 | 17,486                                                                                                                                                                              |\n",
            "|     |                 | 58,941                                                                                                                                                                              |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 |                 | (4)                                                                                                                                                                                 |\n",
            "|     |                 | $                                                                                                                                                                                   |\n",
            "|     |                 | 82,959                                                                                                                                                                              |\n",
            "|     |                 | $                                                                                                                                                                                   |\n",
            "|     |                 | 81,434                                                                                                                                                                              |\n",
            "|     |                 | $                                                                                                                                                                                   |\n",
            "|     |                 | 304,182                                                                                                                                                                             |\n",
            "|     |                 | $                                                                                                                                                                                   |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | Total net sales |                                                                                                                                                                                     |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | (1)             | Products  net  sales  include  amortization  of  the  deferred  value  of  unspecified  software  upgrade  rights,  which  are  bundled  in  the  sales  price  of  the  respective |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                 | product.                                                                                                                                                                            |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 |                 | ®                                                                                                                                                                                   |\n",
            "|     |                 | ®                                                                                                                                                                                   |\n",
            "|     |                 | ®                                                                                                                                                                                   |\n",
            "|     |                 | ®                                                                                                                                                                                   |\n",
            "|     |                 | ®                                                                                                                                                                                   |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | (2)             | Wearables, Home and Accessories net sales include sales of AirPods                                                                                                                  |\n",
            "|     |                 | , Apple TV , Apple Watch , Beats                                                                                                                                                    |\n",
            "|     |                 |  products, HomePod mini                                                                                                                                                             |\n",
            "|     |                 |  and accessories.                                                                                                                                                                   |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 |                 | ®                                                                                                                                                                                   |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | (3)             | Services net sales include sales from the Company’s advertising, AppleCare , cloud, digital content, payment and other services. Services net sales also include                    |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 |                 | amortization of the deferred value of services bundled in the sales price of certain products.                                                                                      |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | (4)             | Includes $3.1 billion of revenue recognized in the three months ended June 25, 2022 that was included in deferred revenue as of March 26, 2022, $3.0 billion of                     |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  12 |                 | revenue recognized in the three months ended June 26, 2021 that was included in deferred revenue as of March 27, 2021, $6.3 billion of revenue recognized in                        |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  13 |                 | the  nine  months  ended  June  25,  2022  that  was  included  in  deferred  revenue  as  of  September  25,  2021,  and  $5.5  billion  of  revenue  recognized  in  the  nine    |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  14 |                 | months ended June 26, 2021 that was included in deferred revenue as of September 26, 2020.                                                                                          |\n",
            "+-----+-----------------+-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 15:\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   0 |                                           |    |          |    |            |    |            |    | June 25, 2022   |    |             |    |            |    |             |\n",
            "+=====+===========================================+====+==========+====+============+====+============+====+=================+====+=============+====+============+====+=============+\n",
            "|   1 |                                           |    |          |    |            |    |            |    |                 |    | Cash and    |    | Current    |    | Non-Current |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   2 |                                           |    | Adjusted |    | Unrealized |    | Unrealized |    | Fair            |    | Cash        |    | Marketable |    | Marketable  |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   3 |                                           |    | Cost     |    | Gains      |    | Losses     |    | Value           |    | Equivalents |    | Securities |    | Securities  |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   4 | Cash                                      | $  | 12,852   | $  | —          | $  | —          | $  | 12,852          | $  | 12,852      | $  | —          | $  | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   5 | (1)                                       |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   6 | Level 1                                   |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "|     | :                                         |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   7 | Money market funds                        |    | 10,970   |    | —          |    | —          |    | 10,970          |    | 10,970      |    | —          |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   8 | Mutual funds                              |    | 252      |    | —          |    | (32)       |    | 220             |    | —           |    | 220        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|   9 | Subtotal                                  |    | 11,222   |    | —          |    | (32)       |    | 11,190          |    | 10,970      |    | 220        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  10 | (2)                                       |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  11 | Level 2                                   |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "|     | :                                         |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  12 | U.S. Treasury securities                  |    | 25,296   |    | —          |    | (1,328)    |    | 23,968          |    | 91          |    | 3,511      |    | 20,366      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  13 | U.S. agency securities                    |    | 5,805    |    | —          |    | (511)      |    | 5,294           |    | 4           |    | 240        |    | 5,050       |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  14 | Non-U.S. government securities            |    | 17,597   |    | 6          |    | (1,023)    |    | 16,580          |    | —           |    | 6,336      |    | 10,244      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  15 | Certificates of deposit and time deposits |    | 3,928    |    | —          |    | —          |    | 3,928           |    | 3,374       |    | 504        |    | 50          |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  16 | Commercial paper                          |    | 966      |    | —          |    | —          |    | 966             |    | 209         |    | 757        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  17 | Corporate debt securities                 |    | 88,912   |    | 15         |    | (6,455)    |    | 82,472          |    | 2           |    | 8,738      |    | 73,732      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  18 | Municipal securities                      |    | 978      |    | —          |    | (26)       |    | 952             |    | —           |    | 203        |    | 749         |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  19 | Mortgage- and asset-backed securities     |    | 23,058   |    | —          |    | (1,952)    |    | 21,106          |    | —           |    | 220        |    | 20,886      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  20 | Subtotal                                  |    | 166,540  |    | 21         |    | (11,295)   |    | 155,266         |    | 3,680       |    | 20,509     |    | 131,077     |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  21 | (3)                                       | $  | 190,614  | $  | 21         | $  | (11,327)   | $  | 179,308         | $  | 27,502      | $  | 20,729     | $  | 131,077     |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "|  22 | Total                                     |    |          |    |            |    |            |    |                 |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+-----------------+----+-------------+----+------------+----+-------------+\n",
            "\n",
            "\n",
            "Table 16:\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   0 |                                           |    |          |    |            |    |            |    | September 25, 2021   |    |             |    |            |    |             |\n",
            "+=====+===========================================+====+==========+====+============+====+============+====+======================+====+=============+====+============+====+=============+\n",
            "|   1 |                                           |    |          |    |            |    |            |    |                      |    | Cash and    |    | Current    |    | Non-Current |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   2 |                                           |    | Adjusted |    | Unrealized |    | Unrealized |    | Fair                 |    | Cash        |    | Marketable |    | Marketable  |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   3 |                                           |    | Cost     |    | Gains      |    | Losses     |    | Value                |    | Equivalents |    | Securities |    | Securities  |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   4 | Cash                                      | $  | 17,305   | $  | —          | $  | —          | $  | 17,305               | $  | 17,305      | $  | —          | $  | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   5 | (1)                                       |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   6 | Level 1                                   |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "|     | :                                         |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   7 | Money market funds                        |    | 9,608    |    | —          |    | —          |    | 9,608                |    | 9,608       |    | —          |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   8 | Mutual funds                              |    | 175      |    | 11         |    | (1)        |    | 185                  |    | —           |    | 185        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|   9 | Subtotal                                  |    | 9,783    |    | 11         |    | (1)        |    | 9,793                |    | 9,608       |    | 185        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  10 | (2)                                       |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  11 | Level 2                                   |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "|     | :                                         |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  12 | Equity securities                         |    | 1,527    |    | —          |    | (564)      |    | 963                  |    | —           |    | 963        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  13 | U.S. Treasury securities                  |    | 22,878   |    | 102        |    | (77)       |    | 22,903               |    | 3,596       |    | 6,625      |    | 12,682      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  14 | U.S. agency securities                    |    | 8,949    |    | 2          |    | (64)       |    | 8,887                |    | 1,775       |    | 1,930      |    | 5,182       |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  15 | Non-U.S. government securities            |    | 20,201   |    | 211        |    | (101)      |    | 20,311               |    | 390         |    | 3,091      |    | 16,830      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  16 | Certificates of deposit and time deposits |    | 1,300    |    | —          |    | —          |    | 1,300                |    | 490         |    | 810        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  17 | Commercial paper                          |    | 2,639    |    | —          |    | —          |    | 2,639                |    | 1,776       |    | 863        |    | —           |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  18 | Corporate debt securities                 |    | 83,883   |    | 1,242      |    | (267)      |    | 84,858               |    | —           |    | 12,327     |    | 72,531      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  19 | Municipal securities                      |    | 967      |    | 14         |    | —          |    | 981                  |    | —           |    | 130        |    | 851         |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  20 | Mortgage- and asset-backed securities     |    | 20,529   |    | 171        |    | (124)      |    | 20,576               |    | —           |    | 775        |    | 19,801      |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  21 | Subtotal                                  |    | 162,873  |    | 1,742      |    | (1,197)    |    | 163,418              |    | 8,027       |    | 27,514     |    | 127,877     |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  22 | (3)                                       | $  | 189,961  | $  | 1,753      | $  | (1,198)    | $  | 190,516              | $  | 34,940      | $  | 27,699     | $  | 127,877     |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "|  23 | Total                                     |    |          |    |            |    |            |    |                      |    |             |    |            |    |             |\n",
            "+-----+-------------------------------------------+----+----------+----+------------+----+------------+----+----------------------+----+-------------+----+------------+----+-------------+\n",
            "\n",
            "\n",
            "Table 17:\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   0 | The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of June 25, 2022 (in millions):                   |                                    |          |    |               |\n",
            "+=====+=================================================================================================================================================================================+====================================+==========+====+===============+\n",
            "|   1 | Due after 1 year through 5 years                                                                                                                                                |                                    |          | $  | 92,970        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   2 | Due after 5 years through 10 years                                                                                                                                              |                                    |          |    | 19,317        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   3 | Due after 10 years                                                                                                                                                              |                                    |          |    | 18,790        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   4 | Total fair value                                                                                                                                                                |                                    |          | $  | 131,077       |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   5 | Derivative Instruments and Hedging                                                                                                                                              |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   6 | The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk. However, the Company may                       |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   7 | choose  not  to  hedge  certain  exposures  for  a  variety  of  reasons,  including  accounting  considerations  or  the  prohibitive  economic  cost  of  hedging  particular |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   8 | exposures.  There  can  be  no  assurance  the  hedges  will  offset  more  than  a  portion  of  the  financial  impact  resulting  from  movements  in  foreign  exchange  or |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|   9 | interest rates.                                                                                                                                                                 |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  10 | Foreign Exchange Risk                                                                                                                                                           |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  11 | To  protect  gross  margins  from  fluctuations  in  foreign  currency  exchange  rates,  the  Company  may  enter  into  forward  contracts,  option  contracts  or  other     |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  12 | instruments, and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure                         |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  13 | associated with revenue and inventory purchases, typically for up to 12 months.                                                                                                 |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  14 | To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company                      |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  15 | may  enter  into  forward  contracts,  cross-currency  swaps  or  other  instruments.  The  Company  designates  these  instruments  as  either  cash  flow  or  fair  value    |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  16 | hedges. As of June 25, 2022, the Company’s hedged term debt– and marketable securities–related foreign currency transactions are expected to be recognized                      |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  17 | within 20 years.                                                                                                                                                                |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  18 | The  Company  may  also  enter  into  derivative  instruments  that  are  not  designated  as  accounting  hedges  to  protect  gross  margins  from  certain  fluctuations  in |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  19 | foreign currency exchange rates, as well as to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain                     |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  20 | assets and liabilities denominated in non-functional currencies.                                                                                                                |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  21 | Interest Rate Risk                                                                                                                                                              |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  22 | To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other               |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  23 | instruments. The Company designates these instruments as either cash flow or fair value hedges.                                                                                 |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  24 | The notional amounts of the Company’s outstanding derivative instruments as of June 25, 2022 and September 25, 2021 were as follows (in millions):                              |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  25 |                                                                                                                                                                                 |                                    | June 25, |    | September 25, |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  26 |                                                                                                                                                                                 |                                    | 2022     |    | 2021          |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  27 | Derivative instruments designated as accounting hedges:                                                                                                                         |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  28 | Foreign exchange contracts                                                                                                                                                      | $                                  | 76,234   | $  | 76,475        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  29 | Interest rate contracts                                                                                                                                                         | $                                  | 20,775   | $  | 16,875        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  30 | Derivative instruments not designated as accounting hedges:                                                                                                                     |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  31 | Foreign exchange contracts                                                                                                                                                      | $                                  | 84,506   | $  | 126,918       |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  32 | The gross fair values of the Company’s derivative assets and liabilities were not material as of June 25, 2022 and September 25, 2021.                                          |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  33 | The gains and losses recognized in other comprehensive income/(loss) and amounts reclassified from accumulated other comprehensive income/(loss) to net                         |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  34 | income for the Company’s derivative instruments designated as cash flow hedges were not material in the three- and nine-month periods ended June 25, 2022                       |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  35 | and June 26, 2021.                                                                                                                                                              |                                    |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "|  36 |                                                                                                                                                                                 | Apple Inc. | Q3 2022 Form 10-Q | 9 |          |    |               |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------+----------+----+---------------+\n",
            "\n",
            "\n",
            "Table 18:\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   0 | The carrying amounts of the Company’s hedged items in fair value hedges as of June 25, 2022 and September 25, 2021 were as follows (in millions):                           |                                     |          |    |               |\n",
            "+=====+=============================================================================================================================================================================+=====================================+==========+====+===============+\n",
            "|   1 |                                                                                                                                                                             |                                     | June 25, |    | September 25, |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   2 |                                                                                                                                                                             |                                     | 2022     |    | 2021          |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   3 | Hedged assets/(liabilities):                                                                                                                                                |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   4 | Current and non-current marketable securities                                                                                                                               | $                                   | 14,250   | $  | 15,954        |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   5 | Current and non-current term debt                                                                                                                                           | $                                   | (19,281) | $  | (17,857)      |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   6 | The gains and losses on the Company’s derivative instruments designated as fair value hedges and the related hedged item adjustments were not material in                   |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   7 | the three- and nine-month periods ended June 25, 2022 and June 26, 2021.                                                                                                    |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   8 | Accounts Receivable                                                                                                                                                         |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|   9 | Trade Receivables                                                                                                                                                           |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  10 | The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized           |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  11 | businesses  and  education,  enterprise  and  government  customers.  The  Company  generally  does  not  require  collateral  from  its  customers;  however,  the         |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  12 | Company will require collateral or third-party credit support in certain instances to limit credit risk. In addition, when possible, the Company attempts to limit credit   |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  13 | risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. These credit-      |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  14 | financing arrangements are directly between the third-party financing company and the end customer. As such, the Company generally does not assume any                      |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  15 | recourse or credit risk sharing related to any of these arrangements.                                                                                                       |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  16 | The Company’s cellular network carriers accounted for 36% and 42% of total trade receivables as of June 25, 2022 and September 25, 2021, respectively.                      |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  17 | Vendor Non-Trade Receivables                                                                                                                                                |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  18 | The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture                      |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  19 | subassemblies  or  assemble  final  products  for  the  Company.  The  Company  purchases  these  components  directly  from  suppliers.  As  of  June  25,  2022,  the     |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  20 | Company  had  two  vendors  that  individually  represented  10%  or  more  of  total  vendor  non-trade  receivables,  which  accounted  for  54%  and  12%.  As  of       |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  21 | September  25,  2021,  the  Company  had  three  vendors  that  individually  represented  10%  or  more  of  total  vendor  non-trade  receivables,  which  accounted  for |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  22 | 52%, 11% and 11%.                                                                                                                                                           |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  23 | Note 4 – Condensed Consolidated Financial Statement Details                                                                                                                 |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  24 | The following tables show the Company’s condensed consolidated financial statement details as of June 25, 2022 and September 25, 2021 (in millions):                        |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  25 | Property, Plant and Equipment, Net                                                                                                                                          |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  26 |                                                                                                                                                                             |                                     | June 25, |    | September 25, |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  27 |                                                                                                                                                                             |                                     | 2022     |    | 2021          |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  28 | Gross property, plant and equipment                                                                                                                                         | $                                   | 111,851  | $  | 109,723       |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  29 | Accumulated depreciation and amortization                                                                                                                                   |                                     | (71,516) |    | (70,283)      |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  30 | Total property, plant and equipment, net                                                                                                                                    | $                                   | 40,335   | $  | 39,440        |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  31 | Other Non-Current Liabilities                                                                                                                                               |                                     |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  32 |                                                                                                                                                                             |                                     | June 25, |    | September 25, |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  33 |                                                                                                                                                                             |                                     | 2022     |    | 2021          |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  34 | Long-term taxes payable                                                                                                                                                     | $                                   | 20,699   | $  | 24,689        |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  35 | Other non-current liabilities                                                                                                                                               |                                     | 32,930   |    | 28,636        |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  36 | Total other non-current liabilities                                                                                                                                         | $                                   | 53,629   | $  | 53,325        |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "|  37 |                                                                                                                                                                             | Apple Inc. | Q3 2022 Form 10-Q | 10 |          |    |               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+----------+----+---------------+\n",
            "\n",
            "\n",
            "Table 19:\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   0 |                                           |    |          | Nine Months Ended   |    |          |         |\n",
            "+=====+===========================================+====+==========+=====================+====+==========+=========+\n",
            "|   1 |                                           |    | June 25, |                     |    | June 26, |         |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   2 |                                           |    | 2022     |                     |    | 2021     |         |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   3 | Maturities 90 days or less:               |    |          |                     |    |          |         |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   4 | Proceeds from commercial paper, net       | $  |          | 4,383               | $  |          | 2,745   |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   5 | Maturities greater than 90 days:          |    |          |                     |    |          |         |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   6 | Proceeds from commercial paper            |    |          | 5,731               |    |          | 3,993   |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   7 | Repayments of commercial paper            |    |          | (5,144)             |    |          | (3,716) |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   8 | Proceeds from commercial paper, net       |    |          | 587                 |    |          | 277     |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "|   9 | Total proceeds from commercial paper, net | $  |          | 4,970               | $  |          | 3,022   |\n",
            "+-----+-------------------------------------------+----+----------+---------------------+----+----------+---------+\n",
            "\n",
            "\n",
            "Table 20:\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   0 | A summary of the Company’s restricted stock unit (“RSU”) activity and related information for the nine months ended June 25, 2022 is as follows:   |                |    |                  |    |               |\n",
            "+=====+====================================================================================================================================================+================+====+==================+====+===============+\n",
            "|   1 |                                                                                                                                                    | Number of      |    | Weighted-Average |    | Aggregate     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   2 |                                                                                                                                                    | RSUs           |    | Grant Date Fair  |    | Fair Value    |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   3 |                                                                                                                                                    | (in thousands) |    | Value Per RSU    |    | (in millions) |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   4 | Balance as of September 25, 2021                                                                                                                   | 240,427        | $  | 75.16            |    |               |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   5 | RSUs granted                                                                                                                                       | 84,927         | $  | 150.02           |    |               |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   6 | RSUs vested                                                                                                                                        | (109,846)      | $  | 70.96            |    |               |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   7 | RSUs canceled                                                                                                                                      | (12,986)       | $  | 98.26            |    |               |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "|   8 | Balance as of June 25, 2022                                                                                                                        | 202,522        | $  | 107.35           | $  | 28,689        |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------+----------------+----+------------------+----+---------------+\n",
            "\n",
            "\n",
            "Table 21:\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   0 |                       |    |          | Three Months Ended   |          |    |          | Nine Months Ended   |          |\n",
            "+=====+=======================+====+==========+======================+==========+====+==========+=====================+==========+\n",
            "|   1 |                       |    | June 25, |                      | June 26, |    | June 25, |                     | June 26, |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   2 |                       |    | 2022     |                      | 2021     |    | 2022     |                     | 2021     |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   3 | Americas:             |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   4 | Net sales             | $  | 37,472   | $                    | 35,870   | $  | 129,850  | $                   | 116,486  |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   5 | Operating income      | $  | 13,914   | $                    | 12,916   | $  | 48,778   | $                   | 40,751   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   6 | Europe:               |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   7 | Net sales             | $  | 19,287   | $                    | 18,943   | $  | 72,323   | $                   | 68,513   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   8 | Operating income      | $  | 7,124    | $                    | 7,085    | $  | 27,174   | $                   | 24,939   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|   9 | Greater China:        |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  10 | Net sales             | $  | 14,604   | $                    | 14,762   | $  | 58,730   | $                   | 53,803   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  11 | Operating income      | $  | 5,760    | $                    | 6,303    | $  | 25,055   | $                   | 22,591   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  12 | Japan:                |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  13 | Net sales             | $  | 5,446    | $                    | 6,464    | $  | 20,277   | $                   | 22,491   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  14 | Operating income      | $  | 2,418    | $                    | 3,031    | $  | 9,263    | $                   | 9,962    |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  15 | Rest of Asia Pacific: |    |          |                      |          |    |          |                     |          |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  16 | Net sales             | $  | 6,150    | $                    | 5,395    | $  | 23,002   | $                   | 21,164   |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "|  17 | Operating income      | $  | 2,367    | $                    | 2,116    | $  | 9,185    | $                   | 7,805    |\n",
            "+-----+-----------------------+----+----------+----------------------+----------+----+----------+---------------------+----------+\n",
            "\n",
            "\n",
            "Table 22:\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   0 | Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations                                                                                       |             |     |               |                                               |                                                              |          |                     |\n",
            "+=====+========================================================================================================================================================================================+=============+=====+===============+===============================================+==============================================================+==========+=====================+\n",
            "|   1 | This  section  and  other  parts  of  this  Quarterly  Report  on  Form  10-Q  (“Form  10-Q”)  contain  forward-looking  statements,  within  the  meaning  of  the  Private           |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   2 | Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on                      |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   3 | certain assumptions and include any statement that does not directly relate to any historical or current fact. For example, statements in this Form 10-Q regarding                     |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   4 | the potential future impact of the COVID-19 pandemic on the Company’s business and results of operations are forward-looking statements. Forward-looking                               |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   5 | statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,”              |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   6 | “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and the Company’s actual results may differ significantly                         |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   7 | from the results discussed in the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I,                    |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   8 | Item 1A of the Company’s Annual Report on Form 10-K for the fiscal year ended September 25, 2021 (the “2021 Form 10-K”) under the heading “Risk Factors.”                              |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|   9 | The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.                                                        |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  10 | Unless  otherwise  stated,  all  information  presented  herein  is  based  on  the  Company’s  fiscal  calendar,  and  references  to  particular  years,  quarters,  months  or      |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  11 | periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years. Each of the terms the                            |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  12 | “Company” and “Apple” as used herein refers collectively to Apple Inc. and its wholly owned subsidiaries, unless otherwise stated.                                                     |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  13 | The following discussion should be read in conjunction with the 2021 Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) and the                              |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  14 | condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Form 10-Q.                                                                       |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  15 | Available Information                                                                                                                                                                  |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  16 | The  Company  periodically  provides  certain                                                                                                                                          | information | for | investors  on | its  corporate  website,  www.apple.com,  and | its                                                          | investor | relations  website, |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  17 | investor.apple.com.  This  includes  press  releases  and  other  information  about  financial  performance,  information  on  environmental,  social  and  corporate                 |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  18 | governance matters, and details related to the Company’s annual meeting of shareholders. The information contained on the websites referenced in this Form                             |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  19 | 10-Q is not incorporated by reference into this filing. Further, the Company’s references to website URLs are intended to be inactive textual references only.                         |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  20 | Business Seasonality and Product Introductions                                                                                                                                         |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  21 | The  Company  has  historically  experienced  higher  net  sales  in  its  first  quarter  compared  to  other  quarters  in  its  fiscal  year  due  in  part  to  seasonal  holiday  |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  22 | demand. Additionally,  new  product  and  service  introductions  can  significantly  impact  net  sales,  cost  of  sales  and  operating  expenses.  The  timing  of  product        |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  23 | introductions can also impact the Company’s net sales to its indirect distribution channels as these channels are filled with new inventory following a product                        |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  24 | launch, and channel inventory of an older product often declines as the launch of a newer product approaches. Net sales can also be affected when consumers                            |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  25 | and distributors anticipate a product introduction.                                                                                                                                    |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  26 | Quarterly Highlights                                                                                                                                                                   |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  27 | Total  net  sales  increased  2%  or  $1.5  billion  during  the  third  quarter  of  2022  compared  to  the  same  quarter  in  2021,  driven  primarily  by  higher  net  sales  of |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  28 | Services and iPhone, partially offset by lower net sales of Mac and Wearables, Home and Accessories. The weakness in foreign currencies relative to the U.S.                           |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  29 | dollar had an unfavorable impact on all Products and Services net sales during the third quarter of 2022.                                                                              |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  30 |                                                                                                                                                                                        |             |     |               | ®                                             |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  31 | At the end of the third quarter of 2022, the Company introduced an all-new MacBook Air                                                                                                 |             |     |               |                                               | and an updated 13-inch MacBook Pro , both powered by the new |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  32 | Apple M2 chip. The Company also announced iOS 16, macOS  Ventura, iPadOS  16 and watchOS  9, updates to its operating systems that are expected to be                                  |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  33 | available in the fall of 2022.                                                                                                                                                         |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "|  34 | The Company repurchased $21.7 billion of its common stock and paid dividends and dividend equivalents of $3.8 billion during the third quarter of 2022.                                |             |     |               |                                               |                                                              |          |                     |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------+-----+---------------+-----------------------------------------------+--------------------------------------------------------------+----------+---------------------+\n",
            "\n",
            "\n",
            "Table 23:\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | COVID-19                                                                                                                                                              |\n",
            "+=====+=======================================================================================================================================================================+\n",
            "|   1 | The COVID-19 pandemic has had, and continues to have, a significant impact around the world, prompting governments and businesses to take unprecedented               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | measures, such as restrictions on travel and business operations, temporary closures of businesses, and quarantine and shelter-in-place orders. The COVID-19          |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | pandemic has at times significantly curtailed global economic activity and caused significant volatility and disruption in global financial markets. The COVID-19     |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | pandemic and the measures taken by many countries in response have affected and could in the future materially impact the Company’s business, results of              |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 | operations and financial condition.                                                                                                                                   |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | Certain  of  the  Company’s  outsourcing  partners,  component  suppliers  and  logistical  service  providers  have  experienced  disruptions  during  the  COVID-19 |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | pandemic, resulting in supply shortages. Similar disruptions could occur in the future.                                                                               |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 24:\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   0 |                                 |    |          | Three Months Ended   |          |        |    |          | Nine Months Ended   |          |        |\n",
            "+=====+=================================+====+==========+======================+==========+========+====+==========+=====================+==========+========+\n",
            "|   1 |                                 |    | June 25, |                      | June 26, |        |    | June 25, |                     | June 26, |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   2 |                                 |    | 2022     |                      | 2021     | Change |    | 2022     |                     | 2021     | Change |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   3 | Net sales by category:          |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   4 | (1)                             |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   5 | iPhone                          | $  | 40,665   | $                    | 39,570   | 3 %    | $  | 162,863  | $                   | 153,105  | 6 %    |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   6 | (1)                             |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   7 | Mac                             |    | 7,382    |                      | 8,235    | (10)%  |    | 28,669   |                     | 26,012   | 10 %   |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   8 | (1)                             |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   9 | iPad                            |    | 7,224    |                      | 7,368    | (2)%   |    | 22,118   |                     | 23,610   | (6)%   |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|  10 | (1)(2)                          |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|  11 | Wearables, Home and Accessories |    | 8,084    |                      | 8,775    | (8)%   |    | 31,591   |                     | 29,582   | 7 %    |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|  12 | (3)                             |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|  13 | Services                        |    | 19,604   |                      | 17,486   | 12 %   |    | 58,941   |                     | 50,148   | 18 %   |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|  14 | Total net sales                 | $  | 82,959   | $                    | 81,434   | 2 %    | $  | 304,182  | $                   | 282,457  | 8 %    |\n",
            "+-----+---------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "\n",
            "\n",
            "Table 25:\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   0 |                                  |    |          | Three Months Ended   |          |        |    |          | Nine Months Ended   |          |        |\n",
            "+=====+==================================+====+==========+======================+==========+========+====+==========+=====================+==========+========+\n",
            "|   1 |                                  |    | June 25, |                      | June 26, |        |    | June 25, |                     | June 26, |        |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   2 |                                  |    | 2022     |                      | 2021     | Change |    | 2022     |                     | 2021     | Change |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   3 | Net sales by reportable segment: |    |          |                      |          |        |    |          |                     |          |        |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   4 | Americas                         | $  | 37,472   | $                    | 35,870   | 4 %    | $  | 129,850  | $                   | 116,486  | 11 %   |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   5 | Europe                           |    | 19,287   |                      | 18,943   | 2 %    |    | 72,323   |                     | 68,513   | 6 %    |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   6 | Greater China                    |    | 14,604   |                      | 14,762   | (1)%   |    | 58,730   |                     | 53,803   | 9 %    |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   7 | Japan                            |    | 5,446    |                      | 6,464    | (16)%  |    | 20,277   |                     | 22,491   | (10)%  |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   8 | Rest of Asia Pacific             |    | 6,150    |                      | 5,395    | 14 %   |    | 23,002   |                     | 21,164   | 9 %    |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "|   9 | Total net sales                  | $  | 82,959   | $                    | 81,434   | 2 %    | $  | 304,182  | $                   | 282,457  | 8 %    |\n",
            "+-----+----------------------------------+----+----------+----------------------+----------+--------+----+----------+---------------------+----------+--------+\n",
            "\n",
            "\n",
            "Table 26:\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   0 | Rest of Asia Pacific                                                                                                                                                       |                    |                   |\n",
            "+=====+============================================================================================================================================================================+====================+===================+\n",
            "|   1 | Rest of Asia Pacific net sales increased during the third quarter of 2022 compared to the third quarter of 2021 due primarily to higher net sales of iPhone and            |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   2 | Services. Year-over-year Rest of Asia Pacific net sales increased during the first nine months of 2022 due primarily to higher net sales of Services, iPhone and           |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   3 | Mac. The weakness in foreign currencies relative to the U.S. dollar had a net unfavorable impact on Rest of Asia Pacific net sales during the third quarter and            |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   4 | first nine months of 2022.                                                                                                                                                 |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   5 | Gross Margin                                                                                                                                                               |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   6 | Products  and  Services  gross  margin  and  gross  margin  percentage  for  the  three-  and  nine-month  periods  ended  June  25,  2022  and  June  26,  2021  were  as |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   7 | follows (dollars in millions):                                                                                                                                             |                    |                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "|   8 |                                                                                                                                                                            | Three Months Ended | Nine Months Ended |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------------------+--------------------+-------------------+\n",
            "\n",
            "\n",
            "Table 27:\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   0 | Operating Expenses                                                                                                                                                                 |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+=====+====================================================================================================================================================================================+====+=====================================+====================+====================+==========+========+==========+===================+===================+==========+\n",
            "|   1 | Operating expenses for the three- and nine-month periods ended June 25, 2022 and June 26, 2021 were as follows (dollars in millions):                                              |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   2 |                                                                                                                                                                                    |    |                                     |                    | Three Months Ended |          |        |          |                   | Nine Months Ended |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   3 |                                                                                                                                                                                    |    |                                     |                    | June 25,           | June 26, |        |          | June 25,          |                   | June 26, |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   4 |                                                                                                                                                                                    |    |                                     |                    | 2022               | 2021     |        |          | 2022              |                   | 2021     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   5 | Research and development                                                                                                                                                           |    | $                                   |                    | 6,797              |          | 5,717  | $        | 19,490            | $                 | 16,142   |\n",
            "|     |                                                                                                                                                                                    |    |                                     |                    | $                  |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   6 | Percentage of total net sales                                                                                                                                                      |    |                                     |                    | 8 %                |          | 7 %    |          |                   | 6 %               | 6 %      |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   7 | Selling, general and administrative                                                                                                                                                |    | $                                   |                    | 6,012              |          | 5,412  | $        | 18,654            | $                 | 16,357   |\n",
            "|     |                                                                                                                                                                                    |    |                                     |                    | $                  |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   8 | Percentage of total net sales                                                                                                                                                      |    |                                     |                    | 7 %                |          | 7 %    |          |                   | 6 %               | 6 %      |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|   9 | Total operating expenses                                                                                                                                                           |    | $                                   |                    | 12,809             |          | 11,129 | $        | 38,144            | $                 | 32,499   |\n",
            "|     |                                                                                                                                                                                    |    |                                     |                    | $                  |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  10 | Percentage of total net sales                                                                                                                                                      |    |                                     |                    | 15 %               |          | 14 %   |          |                   | 13 %              | 12 %     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  11 | Research and Development                                                                                                                                                           |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  12 | The growth in research and development (“R&D”) expense during the third quarter and first nine months of 2022 compared to the same periods in 2021 was                             |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  13 | driven  primarily  by  increases  in  headcount-related  expenses,  engineering  program  costs  and  professional  services.  The  Company  continues  to  believe  that          |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  14 | focused investments in R&D are critical to its future growth and competitive position in the marketplace, and to the development of new and updated products                       |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  15 | and services that are central to the Company’s core business strategy.                                                                                                             |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  16 | Selling, General and Administrative                                                                                                                                                |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  17 | The  growth  in  selling,  general  and  administrative  expense  during  the  third  quarter  and  first  nine  months  of  2022  compared  to  the  same  periods  in  2021  was |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  18 | driven primarily by increases in headcount-related expenses, advertising and professional services.                                                                                |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  19 | Other Income/(Expense), Net                                                                                                                                                        |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  20 | Other income/(expense), net (“OI&E”) for the three- and nine-month periods ended June 25, 2022 and June 26, 2021 was as follows (dollars in millions):                             |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  21 |                                                                                                                                                                                    |    |                                     | Three Months Ended |                    |          |        |          | Nine Months Ended |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  22 |                                                                                                                                                                                    |    | June 25,                            |                    | June 26,           |          |        | June 25, |                   | June 26,          |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  23 |                                                                                                                                                                                    |    | 2022                                |                    | 2021               | Change   |        | 2022     |                   | 2021              | Change   |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  24 | Interest and dividend income                                                                                                                                                       | $  | 722                                 | $                  | 719                |          | $      | 2,072    | $                 | 2,184             |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  25 | Interest expense                                                                                                                                                                   |    | (719)                               |                    | (665)              |          |        | (2,104)  |                   | (1,973)           |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  26 | Other income/(expense), net                                                                                                                                                        |    | (13)                                |                    | 189                |          |        | (65)     |                   | 585               |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  27 | Total other income/(expense), net                                                                                                                                                  | $  | (10)                                | $                  | 243                | (104)%   | $      | (97)     | $                 | 796               | (112)%   |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  28 | OI&E  decreased  during  the  third  quarter  and  first  nine  months  of  2022  compared  to  the  same  periods  in  2021  due  primarily  to  fair  value  adjustments  and    |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  29 | realized losses on marketable securities and higher interest expense, partially offset by foreign exchange gains.                                                                  |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  30 | Provision for Income Taxes                                                                                                                                                         |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  31 | Provision for income taxes, effective tax rate and statutory federal income tax rate for the three- and nine-month periods ended June 25, 2022 and June 26,                        |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  32 | 2021 were as follows (dollars in millions):                                                                                                                                        |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  33 |                                                                                                                                                                                    |    |                                     |                    | Three Months Ended |          |        |          |                   | Nine Months Ended |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  34 |                                                                                                                                                                                    |    |                                     | June 25,           |                    | June 26, |        |          | June 25,          |                   | June 26, |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  35 |                                                                                                                                                                                    |    |                                     |                    | 2022               | 2021     |        |          | 2022              |                   | 2021     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  36 | Provision for income taxes                                                                                                                                                         |    | $                                   |                    | 3,624              |          | 2,625  | $        | 15,364            | $                 | 11,830   |\n",
            "|     |                                                                                                                                                                                    |    |                                     |                    | $                  |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  37 | Effective tax rate                                                                                                                                                                 |    |                                     |                    | 15.7 %             |          | 10.8 % |          |                   | 16.3 %            | 13.8 %   |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  38 | Statutory federal income tax rate                                                                                                                                                  |    |                                     |                    | 21 %               |          | 21 %   |          |                   | 21 %              | 21 %     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  39 | The Company’s effective tax rate for the third quarter and first nine months of 2022 was lower than the statutory federal income tax rate due primarily to a lower                 |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  40 | effective tax rate on foreign earnings, tax benefits from share-based compensation and the impact of the U.S. federal R&D tax credit, partially offset by state                    |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  41 | income taxes.                                                                                                                                                                      |    |                                     |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "|  42 |                                                                                                                                                                                    |    | Apple Inc. | Q3 2022 Form 10-Q | 18 |                    |                    |          |        |          |                   |                   |          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+----+-------------------------------------+--------------------+--------------------+----------+--------+----------+-------------------+-------------------+----------+\n",
            "\n",
            "\n",
            "Table 28:\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | The Company’s effective tax rate for the third quarter of 2022 was higher compared to the third quarter of 2021 due primarily to a higher effective tax rate on                    |\n",
            "+=====+====================================================================================================================================================================================+\n",
            "|   1 | foreign earnings and an adjustment to prior years’ foreign-derived intangible income deductions. The Company’s effective tax rate for the first nine months of                     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | 2022  was  higher  compared  to  the  same  period  in  2021  due  primarily  to  a  higher  effective  tax  rate  on  foreign  earnings,  lower  tax  benefits  from  share-based |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | compensation, and the impact to U.S. foreign tax credits as a result of regulations issued by the U.S. Department of the Treasury in January 2022.                                 |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | Liquidity and Capital Resources                                                                                                                                                    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 | The  Company  believes  its  balances  of  cash,  cash  equivalents  and  unrestricted  marketable  securities,  along  with  cash  generated  by  ongoing  operations  and        |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | continued access to debt markets, will be sufficient to satisfy its cash requirements and capital return program over the next 12 months and beyond.                               |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | The Company’s contractual cash requirements have not changed materially since the 2021 Form 10-K, except for manufacturing purchase obligations.                                   |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | Manufacturing Purchase Obligations                                                                                                                                                 |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | The  Company  utilizes  several  outsourcing  partners  to  manufacture  subassemblies  for  the  Company’s  products  and  to  perform  final  assembly  and  testing  of         |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 | finished  products. The  Company  also  obtains  individual  components  for  its  products  from  a  wide  variety  of  individual  suppliers.  Outsourcing  partners  acquire    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | components and build product based on demand information supplied by the Company, which typically covers periods up to 150 days. As of June 25, 2022, the                          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  12 | Company  had  manufacturing  purchase  obligations  of  $43.1  billion,  with  $43.0  billion  payable  within  12  months.  The  Company’s  manufacturing  purchase               |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  13 | obligations are primarily noncancelable.                                                                                                                                           |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  14 | In  addition  to  its  contractual  cash  requirements,  the  Company  has  a  share  repurchase  program  authorized  by  the  Board  of  Directors  (the  “Program”).  The       |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  15 | Program does not obligate the Company to acquire a minimum amount of shares. As of June 25, 2022, the Company’s quarterly cash dividend was $0.23 per                              |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  16 | share. The Company intends to increase its dividend on an annual basis, subject to declaration by the Board of Directors.                                                          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  17 | Critical Accounting Estimates                                                                                                                                                      |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  18 | The preparation of financial statements and related disclosures in conformity with U.S. generally accepted accounting principles and the Company’s discussion                      |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  19 | and analysis of its financial condition and operating results require the Company’s management to make judgments, assumptions and estimates that affect the                        |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  20 | amounts reported. Note 1, “Summary of Significant Accounting Policies” of the Notes to condensed consolidated Financial Statements in Part I, Item 1 of this                       |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  21 | Form  10-Q  and  in  the  Notes  to  Consolidated  Financial  Statements  in  Part  II,  Item  8  of  the  2021  Form  10-K  describe  the  significant  accounting  policies  and |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  22 | methods  used  in  the  preparation  of  the  Company’s  condensed  consolidated  financial  statements.  There  have  been  no  material  changes  to  the  Company’s             |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  23 | critical accounting estimates since the 2021 Form 10-K.                                                                                                                            |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  24 | Item 3.    Quantitative and Qualitative Disclosures About Market Risk                                                                                                              |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  25 | There have been no material changes to the Company’s market risk during the first nine months of 2022. For a discussion of the Company’s exposure to market                        |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  26 | risk, refer to the Company’s market risk disclosures set forth in Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of the 2021 Form                  |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  27 | 10-K.                                                                                                                                                                              |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  28 | Item 4.    Controls and Procedures                                                                                                                                                 |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  29 | Evaluation of Disclosure Controls and Procedures                                                                                                                                   |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  30 | Based on an evaluation under the supervision and with the participation of the Company’s management, the Company’s principal executive officer and principal                       |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  31 | financial  officer  have  concluded  that  the  Company’s  disclosure  controls  and  procedures  as  defined  in  Rules  13a-15(e)  and  15d-15(e)  under  the  Securities        |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  32 | Exchange Act of 1934, as amended (the “Exchange Act”) were effective as of June 25, 2022 to provide reasonable assurance that information required to be                           |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  33 | disclosed by the Company in reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods                    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  34 | specified  in  the  SEC  rules  and  forms  and  (ii)  accumulated  and  communicated  to  the  Company’s  management,  including  its  principal  executive  officer  and         |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  35 | principal financial officer, as appropriate to allow timely decisions regarding required disclosure.                                                                               |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  36 | Changes in Internal Control over Financial Reporting                                                                                                                               |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  37 | There  were  no  changes  in  the  Company’s  internal  control  over  financial  reporting  during  the  third  quarter  of  2022,  which  were  identified  in  connection  with |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  38 | management’s evaluation required by paragraph (d) of Rules 13a-15 and 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely                       |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  39 | to materially affect, the Company’s internal control over financial reporting.                                                                                                     |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 29:\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   0 | PART II — OTHER INFORMATION                                                                                                                                                                 |                 |                    |\n",
            "+=====+=============================================================================================================================================================================================+=================+====================+\n",
            "|   1 | Item 1.    Legal Proceedings                                                                                                                                                                |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   2 | Epic Games                                                                                                                                                                                  |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   3 | Epic  Games,  Inc.  (“Epic”)  filed  a  lawsuit  in  the  U.S.  District  Court  for  the  Northern  District  of  California  (the  “Northern  California  District  Court”)  against  the |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   4 | Company alleging violations of federal and state antitrust laws and California’s unfair competition law based upon the Company’s operation of its App Store. The                            |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   5 | Company filed a counterclaim for breach of contract. On September 10, 2021, the Northern California District Court ruled in favor of the Company with respect to                            |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   6 | nine  out  of  the  ten  counts  included  in  Epic’s  claim,  and  in  favor  of  the  Company  with  respect  to  the  Company’s  claims  for  breach  of  contract.  The  Northern       |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   7 | California District Court found that certain provisions of the Company’s App Store Review Guidelines violate California’s unfair competition law and issued an                              |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   8 | injunction. Epic appealed the decision. The Company filed a cross-appeal and has been granted a stay pending the appeal.                                                                    |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|   9 | Other Legal Proceedings                                                                                                                                                                     |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  10 | The Company is subject to other legal proceedings and claims that have not been fully resolved and that have arisen in the ordinary course of business. The                                 |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  11 | Company settled certain matters during the third quarter of 2022 that did not individually or in the aggregate have a material impact on the Company’s financial                            |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  12 | condition or operating results. The outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting                            |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  13 | period  for  amounts  above  management’s  expectations,  the  Company’s  financial  condition  and  operating  results  for  that  reporting  period  could  be  materially                |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  14 | adversely affected.                                                                                                                                                                         |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  15 | Item 1A.    Risk Factors                                                                                                                                                                    |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  16 | The Company’s business, reputation, results of operations and financial condition, as well as the price of the Company’s stock, can be affected by a number of                              |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  17 | factors, whether currently known or unknown, including those described in Part I, Item 1A of the 2021 Form 10-K under the heading “Risk Factors.” When any                                  |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  18 | one or more of these risks materialize from time to time, the Company’s business, reputation, results of operations and financial condition, as well as the price of                        |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  19 | the Company’s stock, can be materially and adversely affected. There have been no material changes to the Company’s risk factors since the 2021 Form 10-K.                                  |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  20 | Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds                                                                                                                      |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  21 | Purchases of Equity Securities by the Issuer and Affiliated Purchasers                                                                                                                      |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  22 | Share repurchase activity during the three months ended June 25, 2022 was as follows (in millions, except number of shares, which are reflected in thousands,                               |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  23 | and per share amounts):                                                                                                                                                                     |                 |                    |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "|  24 |                                                                                                                                                                                             | Total Number of | Approximate Dollar |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+-----------------+--------------------+\n",
            "\n",
            "\n",
            "Table 30:\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | Open market and privately negotiated purchases   | 50,027                                                                                                                                                                         |\n",
            "|     |                                                  | $                                                                                                                                                                              |\n",
            "|     |                                                  | 139.06                                                                                                                                                                         |\n",
            "|     |                                                  | 50,027                                                                                                                                                                         |\n",
            "+=====+==================================================+================================================================================================================================================================================+\n",
            "|   1 |                                                  | 142,674                                                                                                                                                                        |\n",
            "|     |                                                  | $                                                                                                                                                                              |\n",
            "|     |                                                  | Total                                                                                                                                                                          |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | (1)                                              | On  April  28,  2022,  the  Board  of  Directors  authorized  the  purchase  of  an  additional  $90  billion  of  the  Company’s  common  stock  under  the  Program.  As  of |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 |                                                  | June 25, 2022, total utilization under the April 2022 authorization was $4.1 billion. During the third quarter of 2022, the Company also utilized the final $17.6              |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 |                                                  | billion under the $90 billion Program authorization approved in April 2021. The Program does not obligate the Company to acquire a minimum amount of shares.                   |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                                                  | Under  the  Program,  shares  may  be  repurchased  in  privately  negotiated  and/or  open  market  transactions,  including  under  plans  complying  with  Rule  10b5-1     |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 |                                                  | under the Exchange Act.                                                                                                                                                        |\n",
            "+-----+--------------------------------------------------+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 31:\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | Item 3.    Defaults Upon Senior Securities                                                                                                                     |\n",
            "+=====+================================================================================================================================================================+\n",
            "|   1 | None.                                                                                                                                                          |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | Item 4.    Mine Safety Disclosures                                                                                                                             |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | Not applicable.                                                                                                                                                |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | Item 5.    Other Information                                                                                                                                   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 | Rule 10b5-1 Trading Plans                                                                                                                                      |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | During the three months ended June 25, 2022, Katherine L. Adams, Timothy D. Cook, Luca Maestri, Deirdre O’Brien and Jeffrey Williams, each an officer for      |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | purposes of Section 16 of the Exchange Act, had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading   |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | plan is a written document that preestablishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | sales of the Company’s stock, including sales of shares acquired under the Company’s employee and director equity plans.                                       |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 | Item 6.    Exhibits                                                                                                                                            |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | Incorporated by Reference                                                                                                                                      |\n",
            "+-----+----------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 32:\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   0 | Item 6.    Exhibits   |                                                                                                   |      |                           |              |\n",
            "+=====+=======================+===================================================================================================+======+===========================+==============+\n",
            "|   1 |                       |                                                                                                   |      | Incorporated by Reference |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   2 |                       |                                                                                                   |      |                           | Filing Date/ |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   3 | Exhibit               |                                                                                                   |      |                           | Period End   |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   4 | Number                | Exhibit Description                                                                               | Form | Exhibit                   | Date         |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   5 | 31.1*                 | Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.                              |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   6 | 31.2*                 | Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.                              |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   7 | 32.1**                | Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.               |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   8 | 101*                  | Inline XBRL Document Set for the condensed consolidated financial statements and accompanying     |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|   9 |                       | notes in Part I, Item 1, “Financial Statements” of this Quarterly Report on Form 10-Q.            |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|  10 | 104*                  | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q, included in the Exhibit 101 |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "|  11 |                       | Inline XBRL Document Set.                                                                         |      |                           |              |\n",
            "+-----+-----------------------+---------------------------------------------------------------------------------------------------+------+---------------------------+--------------+\n",
            "\n",
            "\n",
            "Table 33:\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   0 |                                                                                                                                                               | SIGNATURE                           |            |                         |\n",
            "+=====+===============================================================================================================================================================+=====================================+============+=========================+\n",
            "|   1 | Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned |                                     |            |                         |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   2 | thereunto duly authorized.                                                                                                                                    |                                     |            |                         |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   3 | Date: July 28, 2022                                                                                                                                           |                                     | Apple Inc. |                         |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   4 |                                                                                                                                                               |                                     | By:        | /s/ Luca Maestri        |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   5 |                                                                                                                                                               |                                     |            | Luca Maestri            |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   6 |                                                                                                                                                               |                                     |            | Senior Vice President,  |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   7 |                                                                                                                                                               |                                     |            | Chief Financial Officer |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "|   8 |                                                                                                                                                               | Apple Inc. | Q3 2022 Form 10-Q | 22 |            |                         |\n",
            "+-----+---------------------------------------------------------------------------------------------------------------------------------------------------------------+-------------------------------------+------------+-------------------------+\n",
            "\n",
            "\n",
            "Table 34:\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 |                                   | Exhibit 31.1                                                                                                                                                                 |\n",
            "+=====+===================================+==============================================================================================================================================================================+\n",
            "|   1 |                                   | CERTIFICATION                                                                                                                                                                |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | I, Timothy D. Cook, certify that: |                                                                                                                                                                              |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | 1.                                | I have reviewed this quarterly report on Form 10-Q of Apple Inc.;                                                                                                            |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | 2.                                | Based  on  my  knowledge,  this  report  does  not  contain  any  untrue  statement  of  a  material  fact  or  omit  to  state  a  material  fact  necessary  to  make  the |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                                   | statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;                      |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | 3.                                | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial              |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 |                                   | condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;                                                      |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | 4.                                | The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange               |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 |                                   | Act  Rules  13a-15(e)  and  15d-15(e))  and  internal  control  over  financial  reporting  (as  defined  in  Exchange  Act  Rules  13a-15(f)  and  15d-15(f))  for  the     |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 |                                   | Registrant and have:                                                                                                                                                         |\n",
            "+-----+-----------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 35:\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 |                                                                                                                                                                          | The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange         |\n",
            "+=====+==========================================================================================================================================================================+========================================================================================================================================================================+\n",
            "|   1 | Act  Rules  13a-15(e)  and  15d-15(e))  and  internal  control  over  financial  reporting  (as  defined  in  Exchange  Act  Rules  13a-15(f)  and  15d-15(f))  for  the |                                                                                                                                                                        |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | Registrant and have:                                                                                                                                                     |                                                                                                                                                                        |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | (a)                                                                                                                                                                      | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,                              |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 |                                                                                                                                                                          | to  ensure  that  material  information  relating  to  the  Registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within      |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                                                                                                                                                                          | those entities, particularly during the period in which this report is being prepared;                                                                                 |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | (b)                                                                                                                                                                      | Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our          |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 |                                                                                                                                                                          | supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for         |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 |                                                                                                                                                                          | external purposes in accordance with generally accepted accounting principles;                                                                                         |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | (c)                                                                                                                                                                      | Evaluated  the  effectiveness  of  the  Registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the            |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 |                                                                                                                                                                          | effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and                              |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | (d)                                                                                                                                                                      | Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent                    |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  12 |                                                                                                                                                                          | fiscal  quarter  (the  Registrant’s  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  13 |                                                                                                                                                                          | materially affect, the Registrant’s internal control over financial reporting; and                                                                                     |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 36:\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 |                                | Exhibit 31.2                                                                                                                                                                 |\n",
            "+=====+================================+==============================================================================================================================================================================+\n",
            "|   1 |                                | CERTIFICATION                                                                                                                                                                |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | I, Luca Maestri, certify that: |                                                                                                                                                                              |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | 1.                             | I have reviewed this quarterly report on Form 10-Q of Apple Inc.;                                                                                                            |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | 2.                             | Based  on  my  knowledge,  this  report  does  not  contain  any  untrue  statement  of  a  material  fact  or  omit  to  state  a  material  fact  necessary  to  make  the |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                                | statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;                      |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | 3.                             | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial              |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 |                                | condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;                                                      |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | 4.                             | The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange               |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 |                                | Act  Rules  13a-15(e)  and  15d-15(e))  and  internal  control  over  financial  reporting  (as  defined  in  Exchange  Act  Rules  13a-15(f)  and  15d-15(f))  for  the     |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 |                                | Registrant and have:                                                                                                                                                         |\n",
            "+-----+--------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 37:\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 |                                                                                                                                                                          | The Registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange         |\n",
            "+=====+==========================================================================================================================================================================+========================================================================================================================================================================+\n",
            "|   1 | Act  Rules  13a-15(e)  and  15d-15(e))  and  internal  control  over  financial  reporting  (as  defined  in  Exchange  Act  Rules  13a-15(f)  and  15d-15(f))  for  the |                                                                                                                                                                        |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | Registrant and have:                                                                                                                                                     |                                                                                                                                                                        |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | (a)                                                                                                                                                                      | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,                              |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 |                                                                                                                                                                          | to  ensure  that  material  information  relating  to  the  Registrant,  including  its  consolidated  subsidiaries,  is  made  known  to  us  by  others  within      |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 |                                                                                                                                                                          | those entities, particularly during the period in which this report is being prepared;                                                                                 |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | (b)                                                                                                                                                                      | Designed  such  internal  control  over  financial  reporting,  or  caused  such  internal  control  over  financial  reporting  to  be  designed  under  our          |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 |                                                                                                                                                                          | supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial  statements  for         |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 |                                                                                                                                                                          | external purposes in accordance with generally accepted accounting principles;                                                                                         |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | (c)                                                                                                                                                                      | Evaluated  the  effectiveness  of  the  Registrant’s  disclosure  controls  and  procedures  and  presented  in  this  report  our  conclusions  about  the            |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  10 |                                                                                                                                                                          | effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and                              |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  11 | (d)                                                                                                                                                                      | Disclosed in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent                    |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  12 |                                                                                                                                                                          | fiscal  quarter  (the  Registrant’s  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is  reasonably  likely  to |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|  13 |                                                                                                                                                                          | materially affect, the Registrant’s internal control over financial reporting; and                                                                                     |\n",
            "+-----+--------------------------------------------------------------------------------------------------------------------------------------------------------------------------+------------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n",
            "Table 38:\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   0 | Exhibit 32.1                                                                                                                                                     |\n",
            "+=====+==================================================================================================================================================================+\n",
            "|   1 | CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER                                                                                            |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   2 | PURSUANT TO                                                                                                                                                      |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   3 | 18 U.S.C. SECTION 1350,                                                                                                                                          |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   4 | AS ADOPTED PURSUANT TO                                                                                                                                           |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   5 | SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002                                                                                                                    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   6 | I, Timothy D. Cook, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   7 | that the Quarterly Report of Apple Inc. on Form 10-Q for the period ended June 25, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the    |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   8 | Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "|   9 | operations of Apple Inc. at the dates and for the periods indicated.                                                                                             |\n",
            "+-----+------------------------------------------------------------------------------------------------------------------------------------------------------------------+\n",
            "\n",
            "\n"
          ]
        }
      ],
      "source": [
        "tables = camelot.read_pdf('/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf', pages=\"all\", flavor=\"stream\")\n",
        "\n",
        "if tables:\n",
        "    for i, table in enumerate(tables):\n",
        "        print(f\"Table {i+1}:\")\n",
        "        print(tabulate(table.df, headers='firstrow', tablefmt='grid'))\n",
        "        print(\"\\n\")\n",
        "else:\n",
        "    print(\"No tables found.\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "YiS33SpwX-O8"
      },
      "source": [
        "## Extract by PyPDF2\n",
        "\n",
        "#### Installation\n",
        "\n",
        "https://pypi.org/project/PyPDF2/\n",
        "\n",
        "`pip install PyPDF2`"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "pip install PyPDF2"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "CJcMnD0Fa_G6",
        "outputId": "eb4620ce-c9e4-4c75-a318-f6c3b14d7f09"
      },
      "execution_count": 26,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting PyPDF2\n",
            "  Downloading pypdf2-3.0.1-py3-none-any.whl.metadata (6.8 kB)\n",
            "Downloading pypdf2-3.0.1-py3-none-any.whl (232 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m232.6/232.6 kB\u001b[0m \u001b[31m3.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: PyPDF2\n",
            "Successfully installed PyPDF2-3.0.1\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 32,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "bR8sTqePX-O8",
        "outputId": "9547c5a7-46cd-48ce-c5f9-3fbb0d3c68d2"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "b'PART I \\xe2\\x80\\x94 FINANCIAL  INFORMA TION\\nItem 1.    Financial Statements\\nApple Inc.\\nCONDENSED CONSOLIDA TED ST ATEMENTS OF OPERA TIONS (Unaudited)\\n(In millions, except number of shares which are reflected in thousands and per share amounts)\\nThree Months Ended Nine Months Ended\\nJune 25,\\n2022June 26,\\n2021June 25,\\n2022June 26,\\n2021\\nNet sales:\\n   Products $ 63,355 $ 63,948 $ 245,241 $ 232,309 \\n   Services 19,604 17,486 58,941 50,148 \\nTotal net sales 82,959 81,434 304,182 282,457 \\nCost of sales:\\n   Products 41,485 40,899 155,084 149,476 \\n   Services 5,589 5,280 16,41 1 15,319 \\nTotal cost of sales 47,074 46,179 171,495 164,795 \\nGross margin 35,885 35,255 132,687 117,662 \\nOperating expenses:\\nResearch and development 6,797 5,717 19,490 16,142 \\nSelling, general and administrative 6,012 5,412 18,654 16,357 \\nTotal operating expenses 12,809 11,129 38,144 32,499 \\nOperating income 23,076 24,126 94,543 85,163 \\nOther income/(expense), net (10) 243 (97) 796 \\nIncome before provision for income taxes 23,066 24,369 94,446 85,959 \\nProvision for income taxes 3,624 2,625 15,364 11,830 \\nNet income $ 19,442 $ 21,744 $ 79,082 $ 74,129 \\nEarnings per share:\\nBasic $ 1.20 $ 1.31 $ 4.86 $ 4.42 \\nDiluted $ 1.20 $ 1.30 $ 4.82 $ 4.38 \\nShares used in computing earnings per share:\\nBasic 16,162,945 16,629,371 16,277,824 16,772,656 \\nDiluted 16,262,203 16,781,735 16,394,937 16,941,527 \\nSee accompanying Notes to Condensed Consolidated Financial Statements.\\nApple Inc. | Q3 2022 Form 10-Q | 1'\n"
          ]
        }
      ],
      "source": [
        "import PyPDF2\n",
        "pdf_file = open('/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf', 'rb')\n",
        "read_pdf = PyPDF2.PdfReader(pdf_file)\n",
        "number_of_pages = len(read_pdf.pages)\n",
        "page = read_pdf.pages[3]\n",
        "page_content = page.extract_text()\n",
        "print (page_content.encode('utf-8'))"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "page_content"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 139
        },
        "id": "LUga9gZGcABD",
        "outputId": "2670122b-d0a6-4acd-ead3-e9472c9f9bde"
      },
      "execution_count": 33,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "'PART I — FINANCIAL  INFORMA TION\\nItem 1.    Financial Statements\\nApple Inc.\\nCONDENSED CONSOLIDA TED ST ATEMENTS OF OPERA TIONS (Unaudited)\\n(In millions, except number of shares which are reflected in thousands and per share amounts)\\nThree Months Ended Nine Months Ended\\nJune 25,\\n2022June 26,\\n2021June 25,\\n2022June 26,\\n2021\\nNet sales:\\n   Products $ 63,355 $ 63,948 $ 245,241 $ 232,309 \\n   Services 19,604 17,486 58,941 50,148 \\nTotal net sales 82,959 81,434 304,182 282,457 \\nCost of sales:\\n   Products 41,485 40,899 155,084 149,476 \\n   Services 5,589 5,280 16,41 1 15,319 \\nTotal cost of sales 47,074 46,179 171,495 164,795 \\nGross margin 35,885 35,255 132,687 117,662 \\nOperating expenses:\\nResearch and development 6,797 5,717 19,490 16,142 \\nSelling, general and administrative 6,012 5,412 18,654 16,357 \\nTotal operating expenses 12,809 11,129 38,144 32,499 \\nOperating income 23,076 24,126 94,543 85,163 \\nOther income/(expense), net (10) 243 (97) 796 \\nIncome before provision for income taxes 23,066 24,369 94,446 85,959 \\nProvision for income taxes 3,624 2,625 15,364 11,830 \\nNet income $ 19,442 $ 21,744 $ 79,082 $ 74,129 \\nEarnings per share:\\nBasic $ 1.20 $ 1.31 $ 4.86 $ 4.42 \\nDiluted $ 1.20 $ 1.30 $ 4.82 $ 4.38 \\nShares used in computing earnings per share:\\nBasic 16,162,945 16,629,371 16,277,824 16,772,656 \\nDiluted 16,262,203 16,781,735 16,394,937 16,941,527 \\nSee accompanying Notes to Condensed Consolidated Financial Statements.\\nApple Inc. | Q3 2022 Form 10-Q | 1'"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            }
          },
          "metadata": {},
          "execution_count": 33
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 36,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "lbOadkjWX-O9",
        "outputId": "8c4cecdc-4bb4-48bd-8933-cbac1ba9c1a8"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "['PART I — FINANCIAL  INFORMA TION' 'Item 1.    Financial Statements'\n",
            " 'Apple Inc.'\n",
            " 'CONDENSED CONSOLIDA TED ST ATEMENTS OF OPERA TIONS (Unaudited)'\n",
            " '(In millions, except number of shares which are reflected in thousands and per share amounts)']\n",
            "['Three Months Ended Nine Months Ended' 'June 25,' '2022June 26,'\n",
            " '2021June 25,']\n",
            "['2022June 26,' '2021' 'Net sales:'\n",
            " '   Products $ 63,355 $ 63,948 $ 245,241 $ 232,309 ']\n",
            "['   Services 19,604 17,486 58,941 50,148 '\n",
            " 'Total net sales 82,959 81,434 304,182 282,457 ' 'Cost of sales:'\n",
            " '   Products 41,485 40,899 155,084 149,476 ']\n",
            "['   Services 5,589 5,280 16,41 1 15,319 '\n",
            " 'Total cost of sales 47,074 46,179 171,495 164,795 '\n",
            " 'Gross margin 35,885 35,255 132,687 117,662 ' 'Operating expenses:']\n",
            "['Research and development 6,797 5,717 19,490 16,142 '\n",
            " 'Selling, general and administrative 6,012 5,412 18,654 16,357 '\n",
            " 'Total operating expenses 12,809 11,129 38,144 32,499 '\n",
            " 'Operating income 23,076 24,126 94,543 85,163 ']\n",
            "['Other income/(expense), net (10) 243 (97) 796 '\n",
            " 'Income before provision for income taxes 23,066 24,369 94,446 85,959 '\n",
            " 'Provision for income taxes 3,624 2,625 15,364 11,830 '\n",
            " 'Net income $ 19,442 $ 21,744 $ 79,082 $ 74,129 ']\n",
            "['Earnings per share:' 'Basic $ 1.20 $ 1.31 $ 4.86 $ 4.42 '\n",
            " 'Diluted $ 1.20 $ 1.30 $ 4.82 $ 4.38 '\n",
            " 'Shares used in computing earnings per share:']\n",
            "['Basic 16,162,945 16,629,371 16,277,824 16,772,656 '\n",
            " 'Diluted 16,262,203 16,781,735 16,394,937 16,941,527 '\n",
            " 'See accompanying Notes to Condensed Consolidated Financial Statements.'\n",
            " 'Apple Inc. | Q3 2022 Form 10-Q | 1']\n"
          ]
        }
      ],
      "source": [
        "import numpy\n",
        "\n",
        "table_list = page_content.split('\\n')\n",
        "l = numpy.array_split(table_list, len(table_list)/4)\n",
        "for i in range(0,9):\n",
        "    print(l[i])"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **PyMUpdf**"
      ],
      "metadata": {
        "id": "YIaX1t9boP1N"
      }
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "84740295",
        "outputId": "1b3f3d09-37c5-4405-9761-4e181f0286c9"
      },
      "source": [
        "pip install PyMuPDF"
      ],
      "execution_count": 47,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Collecting PyMuPDF\n",
            "  Downloading pymupdf-1.26.3-cp39-abi3-manylinux_2_28_x86_64.whl.metadata (3.4 kB)\n",
            "Downloading pymupdf-1.26.3-cp39-abi3-manylinux_2_28_x86_64.whl (24.1 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m24.1/24.1 MB\u001b[0m \u001b[31m70.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: PyMuPDF\n",
            "Successfully installed PyMuPDF-1.26.3\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "9e0a3d9b",
        "outputId": "5d3d32d9-d570-4df6-9773-c97b9735d176"
      },
      "source": [
        "import fitz\n",
        "import pandas as pd\n",
        "from tabulate import tabulate\n",
        "\n",
        "pdf_document = fitz.open(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\")\n",
        "\n",
        "for page_num in range(pdf_document.page_count):\n",
        "    page = pdf_document.load_page(page_num)\n",
        "    tables = page.find_tables()\n",
        "\n",
        "    if tables:\n",
        "        print(f\"Tables found on Page {page_num + 1}:\")\n",
        "        for i, table in enumerate(tables):\n",
        "            print(f\"Table {i+1} on Page {page_num + 1}:\")\n",
        "            try:\n",
        "                # Extract data as a list of lists\n",
        "                table_data = table.extract()\n",
        "                # Convert to pandas DataFrame for better display\n",
        "                df = pd.DataFrame(table_data)\n",
        "                print(tabulate(df, headers='firstrow', tablefmt='grid'))\n",
        "            except Exception as e:\n",
        "                print(f\"Could not extract data from table {i+1}: {e}\")\n",
        "            print(\"-\" * 20)\n",
        "    else:\n",
        "        print(f\"No tables found on Page {page_num + 1}\")\n",
        "\n",
        "pdf_document.close()"
      ],
      "execution_count": 48,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Tables found on Page 1:\n",
            "Tables found on Page 2:\n",
            "Tables found on Page 3:\n",
            "Table 1 on Page 3:\n",
            "+-----+-----------+---------------------------------------------------------------------------------------+-----+\n",
            "|   0 | Item 1.   | Financial Statements                                                                  |   1 |\n",
            "+=====+===========+=======================================================================================+=====+\n",
            "|   1 | Item 2.   | Management’s Discussion and Analysis of Financial Condition and Results of Operations |  14 |\n",
            "+-----+-----------+---------------------------------------------------------------------------------------+-----+\n",
            "|   2 | Item 3.   | Quantitative and Qualitative Disclosures About Market Risk                            |  19 |\n",
            "+-----+-----------+---------------------------------------------------------------------------------------+-----+\n",
            "|   3 | Item 4.   | Controls and Procedures                                                               |  19 |\n",
            "+-----+-----------+---------------------------------------------------------------------------------------+-----+\n",
            "--------------------\n",
            "Table 2 on Page 3:\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   0 | Item 1.   | Legal Proceedings                                           |   20 |\n",
            "+=====+===========+=============================================================+======+\n",
            "|   1 | Item 1A.  | Risk Factors                                                |   20 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   2 | Item 2.   | Unregistered Sales of Equity Securities and Use of Proceeds |   20 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   3 | Item 3.   | Defaults Upon Senior Securities                             |   21 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   4 | Item 4.   | Mine Safety Disclosures                                     |   21 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   5 | Item 5.   | Other Information                                           |   21 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "|   6 | Item 6.   | Exhibits                                                    |   21 |\n",
            "+-----+-----------+-------------------------------------------------------------+------+\n",
            "--------------------\n",
            "Tables found on Page 4:\n",
            "Table 1 on Page 4:\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   0 | Products                                     | $          | 63,355   |    | $          | 63,948   |    | $          | 245,241   |    | $          | 232,309   |\n",
            "+=====+==============================================+============+==========+====+============+==========+====+============+===========+====+============+===========+\n",
            "|   1 | Services                                     | 19,604     |          |    | 17,486     |          |    | 58,941     |           |    | 50,148     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   2 | Total net sales                              | 82,959     |          |    | 81,434     |          |    | 304,182    |           |    | 282,457    |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   3 |                                              |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   4 | Cost of sales:                               |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   5 | Products                                     | 41,485     |          |    | 40,899     |          |    | 155,084    |           |    | 149,476    |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   6 | Services                                     | 5,589      |          |    | 5,280      |          |    | 16,411     |           |    | 15,319     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   7 | Total cost of sales                          | 47,074     |          |    | 46,179     |          |    | 171,495    |           |    | 164,795    |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   8 | Gross margin                                 | 35,885     |          |    | 35,255     |          |    | 132,687    |           |    | 117,662    |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|   9 |                                              |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  10 | Operating expenses:                          |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  11 | Research and development                     | 6,797      |          |    | 5,717      |          |    | 19,490     |           |    | 16,142     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  12 | Selling, general and administrative          | 6,012      |          |    | 5,412      |          |    | 18,654     |           |    | 16,357     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  13 | Total operating expenses                     | 12,809     |          |    | 11,129     |          |    | 38,144     |           |    | 32,499     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  14 |                                              |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  15 | Operating income                             | 23,076     |          |    | 24,126     |          |    | 94,543     |           |    | 85,163     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  16 | Other income/(expense), net                  | (10)       |          |    | 243        |          |    | (97)       |           |    | 796        |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  17 | Income before provision for income taxes     | 23,066     |          |    | 24,369     |          |    | 94,446     |           |    | 85,959     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  18 | Provision for income taxes                   | 3,624      |          |    | 2,625      |          |    | 15,364     |           |    | 11,830     |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  19 | Net income                                   | $          | 19,442   |    | $          | 21,744   |    | $          | 79,082    |    | $          | 74,129    |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  20 |                                              |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  21 | Earnings per share:                          |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  22 | Basic                                        | $          | 1.20     |    | $          | 1.31     |    | $          | 4.86      |    | $          | 4.42      |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  23 | Diluted                                      | $          | 1.20     |    | $          | 1.30     |    | $          | 4.82      |    | $          | 4.38      |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  24 |                                              |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  25 | Shares used in computing earnings per share: |            |          |    |            |          |    |            |           |    |            |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  26 | Basic                                        | 16,162,945 |          |    | 16,629,371 |          |    | 16,277,824 |           |    | 16,772,656 |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "|  27 | Diluted                                      | 16,262,203 |          |    | 16,781,735 |          |    | 16,394,937 |           |    | 16,941,527 |           |\n",
            "+-----+----------------------------------------------+------------+----------+----+------------+----------+----+------------+-----------+----+------------+-----------+\n",
            "--------------------\n",
            "Tables found on Page 5:\n",
            "Table 1 on Page 5:\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   0 | Other comprehensive income/(loss):                                           |         | None   |    |      | None   |    |         | None   |    |       | None   |\n",
            "+=====+==============================================================================+=========+========+====+======+========+====+=========+========+====+=======+========+\n",
            "|   1 | Change in foreign currency translation, net of tax                           | (721)   |        |    | 188  |        |    | (1,102) |        |    | 659   |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   2 |                                                                              |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   3 | Change in unrealized gains/losses on derivative instruments, net of tax:     |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   4 | Change in fair value of derivative instruments                               | 852     |        |    | (24) |        |    | 1,548   |        |    | 4     |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   5 | Adjustment for net (gains)/losses realized and included in net income        | 121     |        |    | 17   |        |    | (87)    |        |    | 593   |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   6 | Total change in unrealized gains/losses on derivative instruments            | 973     |        |    | (7)  |        |    | 1,461   |        |    | 597   |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   7 |                                                                              |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   8 | Change in unrealized gains/losses on marketable debt securities, net of tax: |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|   9 | Change in fair value of marketable debt securities                           | (3,150) |        |    | 217  |        |    | (9,959) |        |    | (558) |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|  10 | Adjustment for net (gains)/losses realized and included in net income        | 95      |        |    | (54) |        |    | 140     |        |    | (234) |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|  11 | Total change in unrealized gains/losses on marketable debt                   | (3,055) |        |    | 163  |        |    | (9,819) |        |    | (792) |        |\n",
            "|     | securities                                                                   |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|  12 |                                                                              |         |        |    |      |        |    |         |        |    |       |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|  13 | Total other comprehensive income/(loss)                                      | (2,803) |        |    | 344  |        |    | (9,460) |        |    | 464   |        |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "|  14 | Total comprehensive income                                                   | $       | 16,639 |    | $    | 22,088 |    | $       | 69,622 |    | $     | 74,593 |\n",
            "+-----+------------------------------------------------------------------------------+---------+--------+----+------+--------+----+---------+--------+----+-------+--------+\n",
            "--------------------\n",
            "Tables found on Page 6:\n",
            "Table 1 on Page 6:\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   0 | ASSETS:                                                                                                   | None    | None    | None   | None    | None    |\n",
            "+=====+===========================================================================================================+=========+=========+========+=========+=========+\n",
            "|   1 | Current assets:                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   2 | Cash and cash equivalents                                                                                 | $       | 27,502  |        | $       | 34,940  |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   3 | Marketable securities                                                                                     | 20,729  |         |        | 27,699  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   4 | Accounts receivable, net                                                                                  | 21,803  |         |        | 26,278  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   5 | Inventories                                                                                               | 5,433   |         |        | 6,580   |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   6 | Vendor non-trade receivables                                                                              | 20,439  |         |        | 25,228  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   7 | Other current assets                                                                                      | 16,386  |         |        | 14,111  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   8 | Total current assets                                                                                      | 112,292 |         |        | 134,836 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|   9 |                                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  10 | Non-current assets:                                                                                       |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  11 | Marketable securities                                                                                     | 131,077 |         |        | 127,877 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  12 | Property, plant and equipment, net                                                                        | 40,335  |         |        | 39,440  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  13 | Other non-current assets                                                                                  | 52,605  |         |        | 48,849  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  14 | Total non-current assets                                                                                  | 224,017 |         |        | 216,166 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  15 | Total assets                                                                                              | $       | 336,309 |        | $       | 351,002 |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  16 |                                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  17 | LIABILITIES AND SHAREHOLDERS’ EQUITY:                                                                     |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  18 | Current liabilities:                                                                                      |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  19 | Accounts payable                                                                                          | $       | 48,343  |        | $       | 54,763  |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  20 | Other current liabilities                                                                                 | 48,811  |         |        | 47,493  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  21 | Deferred revenue                                                                                          | 7,728   |         |        | 7,612   |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  22 | Commercial paper                                                                                          | 10,982  |         |        | 6,000   |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  23 | Term debt                                                                                                 | 14,009  |         |        | 9,613   |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  24 | Total current liabilities                                                                                 | 129,873 |         |        | 125,481 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  25 |                                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  26 | Non-current liabilities:                                                                                  |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  27 | Term debt                                                                                                 | 94,700  |         |        | 109,106 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  28 | Other non-current liabilities                                                                             | 53,629  |         |        | 53,325  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  29 | Total non-current liabilities                                                                             | 148,329 |         |        | 162,431 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  30 | Total liabilities                                                                                         | 278,202 |         |        | 287,912 |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  31 |                                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  32 | Commitments and contingencies                                                                             |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  33 |                                                                                                           |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  34 | Shareholders’ equity:                                                                                     |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  35 | Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,095,378 | 62,115  |         |        | 57,365  |         |\n",
            "|     | and 16,426,786 shares issued and outstanding, respectively                                                |         |         |        |         |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  36 | Retained earnings                                                                                         | 5,289   |         |        | 5,562   |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  37 | Accumulated other comprehensive income/(loss)                                                             | (9,297) |         |        | 163     |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  38 | Total shareholders’ equity                                                                                | 58,107  |         |        | 63,090  |         |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "|  39 | Total liabilities and shareholders’ equity                                                                | $       | 336,309 |        | $       | 351,002 |\n",
            "+-----+-----------------------------------------------------------------------------------------------------------+---------+---------+--------+---------+---------+\n",
            "--------------------\n",
            "Tables found on Page 7:\n",
            "Table 1 on Page 7:\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   0 |                                                                 |          | None   |    |          | None   |    |          | None   |    |          | None   |\n",
            "+=====+=================================================================+==========+========+====+==========+========+====+==========+========+====+==========+========+\n",
            "|   1 | Common stock and additional paid-in capital:                    |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   2 | Beginning balances                                              | 61,181   |        |    | 54,203   |        |    | 57,365   |        |    | 50,779   |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   3 | Common stock issued                                             | —        |        |    | —        |        |    | 593      |        |    | 561      |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   4 | Common stock withheld related to net share settlement of equity | (1,371)  |        |    | (1,224)  |        |    | (2,783)  |        |    | (2,460)  |        |\n",
            "|     | awards                                                          |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   5 | Share-based compensation                                        | 2,305    |        |    | 2,010    |        |    | 6,940    |        |    | 6,109    |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   6 | Ending balances                                                 | 62,115   |        |    | 54,989   |        |    | 62,115   |        |    | 54,989   |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   7 |                                                                 |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   8 | Retained earnings:                                              |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|   9 | Beginning balances                                              | 12,712   |        |    | 15,261   |        |    | 5,562    |        |    | 14,966   |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  10 | Net income                                                      | 19,442   |        |    | 21,744   |        |    | 79,082   |        |    | 74,129   |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  11 | Dividends and dividend equivalents declared                     | (3,760)  |        |    | (3,713)  |        |    | (11,058) |        |    | (10,755) |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  12 | Common stock withheld related to net share settlement of equity | (1,403)  |        |    | (1,559)  |        |    | (3,323)  |        |    | (3,606)  |        |\n",
            "|     | awards                                                          |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  13 | Common stock repurchased                                        | (21,702) |        |    | (22,500) |        |    | (64,974) |        |    | (65,501) |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  14 | Ending balances                                                 | 5,289    |        |    | 9,233    |        |    | 5,289    |        |    | 9,233    |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  15 |                                                                 |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  16 | Accumulated other comprehensive income/(loss):                  |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  17 | Beginning balances                                              | (6,494)  |        |    | (286)    |        |    | 163      |        |    | (406)    |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  18 | Other comprehensive income/(loss)                               | (2,803)  |        |    | 344      |        |    | (9,460)  |        |    | 464      |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  19 | Ending balances                                                 | (9,297)  |        |    | 58       |        |    | (9,297)  |        |    | 58       |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  20 |                                                                 |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  21 | Total shareholders’ equity, ending balances                     | $        | 58,107 |    | $        | 64,280 |    | $        | 58,107 |    | $        | 64,280 |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  22 |                                                                 |          |        |    |          |        |    |          |        |    |          |        |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "|  23 | Dividends and dividend equivalents declared per share or RSU    | $        | 0.23   |    | $        | 0.22   |    | $        | 0.67   |    | $        | 0.63   |\n",
            "+-----+-----------------------------------------------------------------+----------+--------+----+----------+--------+----+----------+--------+----+----------+--------+\n",
            "--------------------\n",
            "Tables found on Page 8:\n",
            "Table 1 on Page 8:\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   0 | Operating activities:                                                          |          | None   |    |          | None   |\n",
            "+=====+================================================================================+==========+========+====+==========+========+\n",
            "|   1 | Net income                                                                     | 79,082   |        |    | 74,129   |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   2 | Adjustments to reconcile net income to cash generated by operating activities: |          |        |    |          |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   3 | Depreciation and amortization                                                  | 8,239    |        |    | 8,295    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   4 | Share-based compensation expense                                               | 6,760    |        |    | 5,961    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   5 | Deferred income tax expense/(benefit)                                          | 2,756    |        |    | (737)    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   6 | Other                                                                          | (61)     |        |    | (689)    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   7 | Changes in operating assets and liabilities:                                   |          |        |    |          |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   8 | Accounts receivable, net                                                       | 4,561    |        |    | (1,316)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|   9 | Inventories                                                                    | 1,049    |        |    | (1,213)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  10 | Vendor non-trade receivables                                                   | 4,789    |        |    | 4,892    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  11 | Other current and non-current assets                                           | (3,289)  |        |    | (5,899)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  12 | Accounts payable                                                               | (6,108)  |        |    | (1,786)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  13 | Deferred revenue                                                               | 260      |        |    | 1,738    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  14 | Other current and non-current liabilities                                      | (14)     |        |    | 463      |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  15 | Cash generated by operating activities                                         | 98,024   |        |    | 83,838   |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  16 | Investing activities:                                                          |          |        |    |          |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  17 | Purchases of marketable securities                                             | (70,178) |        |    | (94,052) |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  18 | Proceeds from maturities of marketable securities                              | 24,203   |        |    | 49,880   |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  19 | Proceeds from sales of marketable securities                                   | 33,609   |        |    | 36,745   |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  20 | Payments for acquisition of property, plant and equipment                      | (7,419)  |        |    | (7,862)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  21 | Payments made in connection with business acquisitions, net                    | (169)    |        |    | (13)     |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  22 | Other                                                                          | (1,183)  |        |    | (78)     |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  23 | Cash used in investing activities                                              | (21,137) |        |    | (15,380) |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  24 | Financing activities:                                                          |          |        |    |          |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  25 | Payments for taxes related to net share settlement of equity awards            | (5,915)  |        |    | (5,855)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  26 | Payments for dividends and dividend equivalents                                | (11,138) |        |    | (10,827) |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  27 | Repurchases of common stock                                                    | (64,974) |        |    | (66,223) |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  28 | Proceeds from issuance of term debt, net                                       | —        |        |    | 13,923   |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  29 | Repayments of term debt                                                        | (6,750)  |        |    | (7,500)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  30 | Proceeds from commercial paper, net                                            | 4,970    |        |    | 3,022    |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  31 | Other                                                                          | (148)    |        |    | 489      |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  32 | Cash used in financing activities                                              | (83,955) |        |    | (72,971) |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  33 | Decrease in cash, cash equivalents and restricted cash                         | (7,068)  |        |    | (4,513)  |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  34 | Cash, cash equivalents and restricted cash, ending balances                    | $        | 28,861 |    | $        | 35,276 |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  35 | Supplemental cash flow disclosure:                                             |          |        |    |          |        |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  36 | Cash paid for income taxes, net                                                | $        | 12,251 |    | $        | 18,536 |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "|  37 | Cash paid for interest                                                         | $        | 1,910  |    | $        | 1,870  |\n",
            "+-----+--------------------------------------------------------------------------------+----------+--------+----+----------+--------+\n",
            "--------------------\n",
            "Tables found on Page 9:\n",
            "Table 1 on Page 9:\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   0 | Net income                                | $          |   19,442 |    | $          |   21,744 |    | $          |   79,082 |    | $          |   74,129 |\n",
            "+=====+===========================================+============+==========+====+============+==========+====+============+==========+====+============+==========+\n",
            "|   1 |                                           |            |          |    |            |          |    |            |          |    |            |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   2 | Denominator:                              |            |          |    |            |          |    |            |          |    |            |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   3 | Weighted-average basic shares outstanding | 16,162,945 |          |    | 16,629,371 |          |    | 16,277,824 |          |    | 16,772,656 |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   4 | Effect of dilutive securities             | 99,258     |          |    | 152,364    |          |    | 117,113    |          |    | 168,871    |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   5 | Weighted-average diluted shares           | 16,262,203 |          |    | 16,781,735 |          |    | 16,394,937 |          |    | 16,941,527 |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   6 |                                           |            |          |    |            |          |    |            |          |    |            |          |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   7 | Basic earnings per share                  | $          |      1.2 |    | $          |     1.31 |    | $          |     4.86 |    | $          |     4.42 |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "|   8 | Diluted earnings per share                | $          |      1.2 |    | $          |     1.3  |    | $          |     4.82 |    | $          |     4.38 |\n",
            "+-----+-------------------------------------------+------------+----------+----+------------+----------+----+------------+----------+----+------------+----------+\n",
            "--------------------\n",
            "Tables found on Page 10:\n",
            "Table 1 on Page 10:\n",
            "+-----+----------------------------------------+---------+--------+----+---------+--------+----+----------+---------+----+----------+---------+\n",
            "|   0 | Mac ® (1)                              | 7,382   | None   |    | 8,235   | None   |    | 28,669   | None    |    | 26,012   | None    |\n",
            "+=====+========================================+=========+========+====+=========+========+====+==========+=========+====+==========+=========+\n",
            "|   1 | iPad® (1)                              | 7,224   |        |    | 7,368   |        |    | 22,118   |         |    | 23,610   |         |\n",
            "+-----+----------------------------------------+---------+--------+----+---------+--------+----+----------+---------+----+----------+---------+\n",
            "|   2 | Wearables, Home and Accessories (1)(2) | 8,084   |        |    | 8,775   |        |    | 31,591   |         |    | 29,582   |         |\n",
            "+-----+----------------------------------------+---------+--------+----+---------+--------+----+----------+---------+----+----------+---------+\n",
            "|   3 | Services (3)                           | 19,604  |        |    | 17,486  |        |    | 58,941   |         |    | 50,148   |         |\n",
            "+-----+----------------------------------------+---------+--------+----+---------+--------+----+----------+---------+----+----------+---------+\n",
            "|   4 | Total net sales (4)                    | $       | 82,959 |    | $       | 81,434 |    | $        | 304,182 |    | $        | 282,457 |\n",
            "+-----+----------------------------------------+---------+--------+----+---------+--------+----+----------+---------+----+----------+---------+\n",
            "--------------------\n",
            "Tables found on Page 11:\n",
            "Table 1 on Page 11:\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   0 | Level 1 (1):                              |         | None    |    |    |   None |    |          | None     |    |         | None    |    |        | None   |    |        | None   |    |         | None    |\n",
            "+=====+===========================================+=========+=========+====+====+========+====+==========+==========+====+=========+=========+====+========+========+====+========+========+====+=========+=========+\n",
            "|   1 | Money market funds                        | 10,970  |         |    | —  |        |    | —        |          |    | 10,970  |         |    | 10,970 |        |    | —      |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   2 | Mutual funds                              | 252     |         |    | —  |        |    | (32)     |          |    | 220     |         |    | —      |        |    | 220    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   3 | Subtotal                                  | 11,222  |         |    | —  |        |    | (32)     |          |    | 11,190  |         |    | 10,970 |        |    | 220    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   4 | Level 2 (2):                              |         |         |    |    |        |    |          |          |    |         |         |    |        |        |    |        |        |    |         |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   5 | U.S. Treasury securities                  | 25,296  |         |    | —  |        |    | (1,328)  |          |    | 23,968  |         |    | 91     |        |    | 3,511  |        |    | 20,366  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   6 | U.S. agency securities                    | 5,805   |         |    | —  |        |    | (511)    |          |    | 5,294   |         |    | 4      |        |    | 240    |        |    | 5,050   |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   7 | Non-U.S. government securities            | 17,597  |         |    | 6  |        |    | (1,023)  |          |    | 16,580  |         |    | —      |        |    | 6,336  |        |    | 10,244  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   8 | Certificates of deposit and time deposits | 3,928   |         |    | —  |        |    | —        |          |    | 3,928   |         |    | 3,374  |        |    | 504    |        |    | 50      |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|   9 | Commercial paper                          | 966     |         |    | —  |        |    | —        |          |    | 966     |         |    | 209    |        |    | 757    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|  10 | Corporate debt securities                 | 88,912  |         |    | 15 |        |    | (6,455)  |          |    | 82,472  |         |    | 2      |        |    | 8,738  |        |    | 73,732  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|  11 | Municipal securities                      | 978     |         |    | —  |        |    | (26)     |          |    | 952     |         |    | —      |        |    | 203    |        |    | 749     |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|  12 | Mortgage- and asset-backed securities     | 23,058  |         |    | —  |        |    | (1,952)  |          |    | 21,106  |         |    | —      |        |    | 220    |        |    | 20,886  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|  13 | Subtotal                                  | 166,540 |         |    | 21 |        |    | (11,295) |          |    | 155,266 |         |    | 3,680  |        |    | 20,509 |        |    | 131,077 |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "|  14 | Total (3)                                 | $       | 190,614 |    | $  |     21 |    | $        | (11,327) |    | $       | 179,308 |    | $      | 27,502 |    | $      | 20,729 |    | $       | 131,077 |\n",
            "+-----+-------------------------------------------+---------+---------+----+----+--------+----+----------+----------+----+---------+---------+----+--------+--------+----+--------+--------+----+---------+---------+\n",
            "--------------------\n",
            "Table 2 on Page 11:\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   0 | Level 1 (1):                              |         | None    |    |       | None   |    |         | None    |    |         | None    |    |       | None   |    |        | None   |    |         | None    |\n",
            "+=====+===========================================+=========+=========+====+=======+========+====+=========+=========+====+=========+=========+====+=======+========+====+========+========+====+=========+=========+\n",
            "|   1 | Money market funds                        | 9,608   |         |    | —     |        |    | —       |         |    | 9,608   |         |    | 9,608 |        |    | —      |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   2 | Mutual funds                              | 175     |         |    | 11    |        |    | (1)     |         |    | 185     |         |    | —     |        |    | 185    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   3 | Subtotal                                  | 9,783   |         |    | 11    |        |    | (1)     |         |    | 9,793   |         |    | 9,608 |        |    | 185    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   4 | Level 2 (2):                              |         |         |    |       |        |    |         |         |    |         |         |    |       |        |    |        |        |    |         |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   5 | Equity securities                         | 1,527   |         |    | —     |        |    | (564)   |         |    | 963     |         |    | —     |        |    | 963    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   6 | U.S. Treasury securities                  | 22,878  |         |    | 102   |        |    | (77)    |         |    | 22,903  |         |    | 3,596 |        |    | 6,625  |        |    | 12,682  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   7 | U.S. agency securities                    | 8,949   |         |    | 2     |        |    | (64)    |         |    | 8,887   |         |    | 1,775 |        |    | 1,930  |        |    | 5,182   |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   8 | Non-U.S. government securities            | 20,201  |         |    | 211   |        |    | (101)   |         |    | 20,311  |         |    | 390   |        |    | 3,091  |        |    | 16,830  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|   9 | Certificates of deposit and time deposits | 1,300   |         |    | —     |        |    | —       |         |    | 1,300   |         |    | 490   |        |    | 810    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  10 | Commercial paper                          | 2,639   |         |    | —     |        |    | —       |         |    | 2,639   |         |    | 1,776 |        |    | 863    |        |    | —       |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  11 | Corporate debt securities                 | 83,883  |         |    | 1,242 |        |    | (267)   |         |    | 84,858  |         |    | —     |        |    | 12,327 |        |    | 72,531  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  12 | Municipal securities                      | 967     |         |    | 14    |        |    | —       |         |    | 981     |         |    | —     |        |    | 130    |        |    | 851     |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  13 | Mortgage- and asset-backed securities     | 20,529  |         |    | 171   |        |    | (124)   |         |    | 20,576  |         |    | —     |        |    | 775    |        |    | 19,801  |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  14 | Subtotal                                  | 162,873 |         |    | 1,742 |        |    | (1,197) |         |    | 163,418 |         |    | 8,027 |        |    | 27,514 |        |    | 127,877 |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "|  15 | Total (3)                                 | $       | 189,961 |    | $     | 1,753  |    | $       | (1,198) |    | $       | 190,516 |    | $     | 34,940 |    | $      | 27,699 |    | $       | 127,877 |\n",
            "+-----+-------------------------------------------+---------+---------+----+-------+--------+----+---------+---------+----+---------+---------+----+-------+--------+----+--------+--------+----+---------+---------+\n",
            "--------------------\n",
            "Tables found on Page 12:\n",
            "Table 1 on Page 12:\n",
            "+-----+--------------------------------------+----------+---------+\n",
            "|   0 | Due after 5 years through 10 years   | 19,317   | None    |\n",
            "+=====+======================================+==========+=========+\n",
            "|   1 | Due after 10 years                   | 18,790   |         |\n",
            "+-----+--------------------------------------+----------+---------+\n",
            "|   2 | Total fair value                     | $        | 131,077 |\n",
            "+-----+--------------------------------------+----------+---------+\n",
            "--------------------\n",
            "Table 2 on Page 12:\n",
            "+-----+-------------------------------------------------------------+-----+----------+----+-----+----------+\n",
            "|   0 | Foreign exchange contracts                                  | $   | 76,234   |    | $   | 76,475   |\n",
            "+=====+=============================================================+=====+==========+====+=====+==========+\n",
            "|   1 | Interest rate contracts                                     | $   | 20,775   |    | $   | 16,875   |\n",
            "+-----+-------------------------------------------------------------+-----+----------+----+-----+----------+\n",
            "|   2 |                                                             |     |          |    |     |          |\n",
            "+-----+-------------------------------------------------------------+-----+----------+----+-----+----------+\n",
            "|   3 | Derivative instruments not designated as accounting hedges: |     |          |    |     |          |\n",
            "+-----+-------------------------------------------------------------+-----+----------+----+-----+----------+\n",
            "|   4 | Foreign exchange contracts                                  | $   | 84,506   |    | $   | 126,918  |\n",
            "+-----+-------------------------------------------------------------+-----+----------+----+-----+----------+\n",
            "--------------------\n",
            "Tables found on Page 13:\n",
            "Table 1 on Page 13:\n",
            "+-----+-------------------------------------------------+-----+----------+----+-----+----------+\n",
            "|   0 | Current and non-current marketable securities   | $   | 14,250   |    | $   | 15,954   |\n",
            "+=====+=================================================+=====+==========+====+=====+==========+\n",
            "|   1 | Current and non-current term debt               | $   | (19,281) |    | $   | (17,857) |\n",
            "+-----+-------------------------------------------------+-----+----------+----+-----+----------+\n",
            "--------------------\n",
            "Table 2 on Page 13:\n",
            "+-----+---------------------------------------------+------------+--------+----+------------+--------+\n",
            "|   0 | Accumulated depreciation and amortization   | (71,516)   | None   |    | (70,283)   | None   |\n",
            "+=====+=============================================+============+========+====+============+========+\n",
            "|   1 | Total property, plant and equipment, net    | $          | 40,335 |    | $          | 39,440 |\n",
            "+-----+---------------------------------------------+------------+--------+----+------------+--------+\n",
            "--------------------\n",
            "Table 3 on Page 13:\n",
            "+-----+-------------------------------------+----------+--------+----+----------+--------+\n",
            "|   0 | Other non-current liabilities       | 32,930   | None   |    | 28,636   | None   |\n",
            "+=====+=====================================+==========+========+====+==========+========+\n",
            "|   1 | Total other non-current liabilities | $        | 53,629 |    | $        | 53,325 |\n",
            "+-----+-------------------------------------+----------+--------+----+----------+--------+\n",
            "--------------------\n",
            "Tables found on Page 14:\n",
            "Table 1 on Page 14:\n",
            "+-----+-----------------------------------+---------+--------+-----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "|   0 | Interest expense                  | (719)   | None   |     | (665)   |   None |    | (2,104)   | None   |    | (1,973)   |   None |\n",
            "+=====+===================================+=========+========+=====+=========+========+====+===========+========+====+===========+========+\n",
            "|   1 | Other income/(expense), net       | (13)    |        | 189 |         |        |    | (65)      |        |    | 585       |        |\n",
            "+-----+-----------------------------------+---------+--------+-----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "|   2 | Total other income/(expense), net | $       | (10)   |     | $       |    243 |    | $         | (97)   |    | $         |    796 |\n",
            "+-----+-----------------------------------+---------+--------+-----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "--------------------\n",
            "Table 2 on Page 14:\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   0 | Proceeds from commercial paper, net       | $       | 4,383   |    | $       | 2,745   |\n",
            "+=====+===========================================+=========+=========+====+=========+=========+\n",
            "|   1 |                                           |         |         |    |         |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   2 | Maturities greater than 90 days:          |         |         |    |         |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   3 | Proceeds from commercial paper            | 5,731   |         |    | 3,993   |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   4 | Repayments of commercial paper            | (5,144) |         |    | (3,716) |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   5 | Proceeds from commercial paper, net       | 587     |         |    | 277     |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   6 |                                           |         |         |    |         |         |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "|   7 | Total proceeds from commercial paper, net | $       | 4,970   |    | $       | 3,022   |\n",
            "+-----+-------------------------------------------+---------+---------+----+---------+---------+\n",
            "--------------------\n",
            "Tables found on Page 15:\n",
            "Table 1 on Page 15:\n",
            "+-----+-----------------------------+-----------+----+-----+----------+----+----+--------+\n",
            "|   0 | RSUs granted                | 84,927    |    | $   |   150.02 |    |    | None   |\n",
            "+=====+=============================+===========+====+=====+==========+====+====+========+\n",
            "|   1 | RSUs vested                 | (109,846) |    | $   |    70.96 |    |    |        |\n",
            "+-----+-----------------------------+-----------+----+-----+----------+----+----+--------+\n",
            "|   2 | RSUs canceled               | (12,986)  |    | $   |    98.26 |    |    |        |\n",
            "+-----+-----------------------------+-----------+----+-----+----------+----+----+--------+\n",
            "|   3 | Balance as of June 25, 2022 | 202,522   |    | $   |   107.35 |    | $  | 28,689 |\n",
            "+-----+-----------------------------+-----------+----+-----+----------+----+----+--------+\n",
            "--------------------\n",
            "Table 2 on Page 15:\n",
            "+-----+------------------------------------------------------------------+-----+-----------+----+-----+-----------+----+-----+-----------+----+-----+-----------+\n",
            "| 0   | Income tax benefit related to share-based compensation expense   | $   | (1,231)   |    | $   | (1,319)   |    | $   | (3,416)   |    | $   | (3,518)   |\n",
            "+=====+==================================================================+=====+===========+====+=====+===========+====+=====+===========+====+=====+===========+\n",
            "+-----+------------------------------------------------------------------+-----+-----------+----+-----+-----------+----+-----+-----------+----+-----+-----------+\n",
            "--------------------\n",
            "Table 3 on Page 15:\n",
            "+-----+-------------------------------------------+---------+--------+----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "|   0 | Cost of warranty claims                   | (534)   | None   |    | (636)   | None   |    | (1,787)   | None   |    | (2,008)   | None   |\n",
            "+=====+===========================================+=========+========+====+=========+========+====+===========+========+====+===========+========+\n",
            "|   1 | Accruals for product warranty             | 177     |        |    | 384     |        |    | 1,272     |        |    | 2,186     |        |\n",
            "+-----+-------------------------------------------+---------+--------+----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "|   2 | Ending accrued warranty and related costs | $       | 2,849  |    | $       | 3,532  |    | $         | 2,849  |    | $         | 3,532  |\n",
            "+-----+-------------------------------------------+---------+--------+----+---------+--------+----+-----------+--------+----+-----------+--------+\n",
            "--------------------\n",
            "Tables found on Page 16:\n",
            "Table 1 on Page 16:\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   0 | Net sales             | $   | 37,472   |    | $   | 35,870   |    | $   | 129,850   |    | $   | 116,486   |\n",
            "+=====+=======================+=====+==========+====+=====+==========+====+=====+===========+====+=====+===========+\n",
            "|   1 | Operating income      | $   | 13,914   |    | $   | 12,916   |    | $   | 48,778    |    | $   | 40,751    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   2 |                       |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   3 | Europe:               |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   4 | Net sales             | $   | 19,287   |    | $   | 18,943   |    | $   | 72,323    |    | $   | 68,513    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   5 | Operating income      | $   | 7,124    |    | $   | 7,085    |    | $   | 27,174    |    | $   | 24,939    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   6 |                       |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   7 | Greater China:        |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   8 | Net sales             | $   | 14,604   |    | $   | 14,762   |    | $   | 58,730    |    | $   | 53,803    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|   9 | Operating income      | $   | 5,760    |    | $   | 6,303    |    | $   | 25,055    |    | $   | 22,591    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  10 |                       |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  11 | Japan:                |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  12 | Net sales             | $   | 5,446    |    | $   | 6,464    |    | $   | 20,277    |    | $   | 22,491    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  13 | Operating income      | $   | 2,418    |    | $   | 3,031    |    | $   | 9,263     |    | $   | 9,962     |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  14 |                       |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  15 | Rest of Asia Pacific: |     |          |    |     |          |    |     |           |    |     |           |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  16 | Net sales             | $   | 6,150    |    | $   | 5,395    |    | $   | 23,002    |    | $   | 21,164    |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "|  17 | Operating income      | $   | 2,367    |    | $   | 2,116    |    | $   | 9,185     |    | $   | 7,805     |\n",
            "+-----+-----------------------+-----+----------+----+-----+----------+----+-----+-----------+----+-----+-----------+\n",
            "--------------------\n",
            "Table 2 on Page 16:\n",
            "+-----+-------------------------------------+---------+--------+----+---------+----------+----+-----------------------+--------+--------+----------+--------+\n",
            "|   0 | Segment operating income $ 31,583   | None    | None   |    | $       | 31,451   |    | $ 119,455 $ 106,048   | None   | None   | None     | None   |\n",
            "+=====+=====================================+=========+========+====+=========+==========+====+=======================+========+========+==========+========+\n",
            "|   1 | Research and development expense    | (6,797) |        |    | (5,717) |          |    | (19,490)              |        |        | (16,142) |        |\n",
            "+-----+-------------------------------------+---------+--------+----+---------+----------+----+-----------------------+--------+--------+----------+--------+\n",
            "|   2 | Other corporate expenses, net       | (1,710) |        |    | (1,608) |          |    | (5,422)               |        |        | (4,743)  |        |\n",
            "+-----+-------------------------------------+---------+--------+----+---------+----------+----+-----------------------+--------+--------+----------+--------+\n",
            "|   3 | Total operating income              | $       | 23,076 |    | $       | 24,126   |    | $                     | 94,543 |        | $        | 85,163 |\n",
            "+-----+-------------------------------------+---------+--------+----+---------+----------+----+-----------------------+--------+--------+----------+--------+\n",
            "--------------------\n",
            "Tables found on Page 17:\n",
            "Tables found on Page 18:\n",
            "Table 1 on Page 18:\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   0 | Net sales by category:                 |        | None   |    |        | None   |    |      | None   |    |        | None    |    |        | None    |    |     | None   |\n",
            "+=====+========================================+========+========+====+========+========+====+======+========+====+========+=========+====+========+=========+====+=====+========+\n",
            "|   1 | iPhone (1)                             | $      | 40,665 |    | $      | 39,570 |    | 3    | %      |    | $      | 162,863 |    | $      | 153,105 |    | 6   | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   2 | Mac (1)                                | 7,382  |        |    | 8,235  |        |    | (10) | %      |    | 28,669 |         |    | 26,012 |         |    | 10  | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   3 | iPad (1)                               | 7,224  |        |    | 7,368  |        |    | (2)  | %      |    | 22,118 |         |    | 23,610 |         |    | (6) | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   4 | Wearables, Home and Accessories (1)(2) | 8,084  |        |    | 8,775  |        |    | (8)  | %      |    | 31,591 |         |    | 29,582 |         |    | 7   | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   5 | Services (3)                           | 19,604 |        |    | 17,486 |        |    | 12   | %      |    | 58,941 |         |    | 50,148 |         |    | 18  | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "|   6 | Total net sales                        | $      | 82,959 |    | $      | 81,434 |    | 2    | %      |    | $      | 304,182 |    | $      | 282,457 |    | 8   | %      |\n",
            "+-----+----------------------------------------+--------+--------+----+--------+--------+----+------+--------+----+--------+---------+----+--------+---------+----+-----+--------+\n",
            "--------------------\n",
            "Tables found on Page 19:\n",
            "Table 1 on Page 19:\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "|   0 | Americas             | $      | 37,472   |    | $      | 35,870   |    | 4    | %   |    | $      | 129,850   |    | $      | 116,486   |    | 11   | %   |\n",
            "+=====+======================+========+==========+====+========+==========+====+======+=====+====+========+===========+====+========+===========+====+======+=====+\n",
            "|   1 | Europe               | 19,287 |          |    | 18,943 |          |    | 2    | %   |    | 72,323 |           |    | 68,513 |           |    | 6    | %   |\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "|   2 | Greater China        | 14,604 |          |    | 14,762 |          |    | (1)  | %   |    | 58,730 |           |    | 53,803 |           |    | 9    | %   |\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "|   3 | Japan                | 5,446  |          |    | 6,464  |          |    | (16) | %   |    | 20,277 |           |    | 22,491 |           |    | (10) | %   |\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "|   4 | Rest of Asia Pacific | 6,150  |          |    | 5,395  |          |    | 14   | %   |    | 23,002 |           |    | 21,164 |           |    | 9    | %   |\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "|   5 | Total net sales      | $      | 82,959   |    | $      | 81,434   |    | 2    | %   |    | $      | 304,182   |    | $      | 282,457   |    | 8    | %   |\n",
            "+-----+----------------------+--------+----------+----+--------+----------+----+------+-----+----+--------+-----------+----+--------+-----------+----+------+-----+\n",
            "--------------------\n",
            "Tables found on Page 20:\n",
            "Table 1 on Page 20:\n",
            "+-----+--------------------+--------+----------+----+--------+----------+----+--------+----------+----+--------+----------+\n",
            "|   0 | Products           | $      | 21,870   |    | $      | 23,049   |    | $      | 90,157   |    | $      | 82,833   |\n",
            "+=====+====================+========+==========+====+========+==========+====+========+==========+====+========+==========+\n",
            "|   1 | Services           | 14,015 |          |    | 12,206 |          |    | 42,530 |          |    | 34,829 |          |\n",
            "+-----+--------------------+--------+----------+----+--------+----------+----+--------+----------+----+--------+----------+\n",
            "|   2 | Total gross margin | $      | 35,885   |    | $      | 35,255   |    | $      | 132,687  |    | $      | 117,662  |\n",
            "+-----+--------------------+--------+----------+----+--------+----------+----+--------+----------+----+--------+----------+\n",
            "--------------------\n",
            "Table 2 on Page 20:\n",
            "+-----+-------------------------------+--------+-----+----+--------+-----+----+--------+-----+--------+-----+\n",
            "|   0 | Products                      |   34.5 | %   |    |   36.0 | %   |    |   36.8 | %   |   35.7 | %   |\n",
            "+=====+===============================+========+=====+====+========+=====+====+========+=====+========+=====+\n",
            "|   1 | Services                      |   71.5 | %   |    |   69.8 | %   |    |   72.2 | %   |   69.5 | %   |\n",
            "+-----+-------------------------------+--------+-----+----+--------+-----+----+--------+-----+--------+-----+\n",
            "|   2 | Total gross margin percentage |   43.3 | %   |    |   43.3 | %   |    |   43.6 | %   |   41.7 | %   |\n",
            "+-----+-------------------------------+--------+-----+----+--------+-----+----+--------+-----+--------+-----+\n",
            "--------------------\n",
            "Tables found on Page 21:\n",
            "Table 1 on Page 21:\n",
            "+-----+-------------------------------------+----------+-----+----+-----+--------+-----+----+-----+--------+-----+----+-----+--------+-----+\n",
            "|   0 | Percentage of total net sales       | 8        | %   |    | 7   | None   | %   |    | 6   | None   | %   |    | 6   | None   | %   |\n",
            "+=====+=====================================+==========+=====+====+=====+========+=====+====+=====+========+=====+====+=====+========+=====+\n",
            "|   1 | Selling, general and administrative | $ 6,012  |     |    | $   | 5,412  |     |    | $   | 18,654 |     |    | $   | 16,357 |     |\n",
            "+-----+-------------------------------------+----------+-----+----+-----+--------+-----+----+-----+--------+-----+----+-----+--------+-----+\n",
            "|   2 | Percentage of total net sales       | 7        | %   |    | 7   |        | %   |    | 6   |        | %   |    | 6   |        | %   |\n",
            "+-----+-------------------------------------+----------+-----+----+-----+--------+-----+----+-----+--------+-----+----+-----+--------+-----+\n",
            "|   3 | Total operating expenses            | $ 12,809 |     |    | $   | 11,129 |     |    | $   | 38,144 |     |    | $   | 32,499 |     |\n",
            "+-----+-------------------------------------+----------+-----+----+-----+--------+-----+----+-----+--------+-----+----+-----+--------+-----+\n",
            "|   4 | Percentage of total net sales       | 15       | %   |    | 14  |        | %   |    | 13  |        | %   |    | 12  |        | %   |\n",
            "+-----+-------------------------------------+----------+-----+----+-----+--------+-----+----+-----+--------+-----+----+-----+--------+-----+\n",
            "--------------------\n",
            "Table 2 on Page 21:\n",
            "+-----+-----------------------------------+---------+--------+----+---------+--------+----+-------+--------+------+-----------+--------+----+-----------+--------+----+-------+--------+\n",
            "|   0 | Interest expense                  | (719)   | None   |    | (665)   |   None |    |       | None   |      | (2,104)   | None   |    | (1,973)   |   None |    |       | None   |\n",
            "+=====+===================================+=========+========+====+=========+========+====+=======+========+======+===========+========+====+===========+========+====+=======+========+\n",
            "|   1 | Other income/(expense), net       | (13)    |        |    | 189     |        |    |       |        | (65) |           |        |    | 585       |        |    |       |        |\n",
            "+-----+-----------------------------------+---------+--------+----+---------+--------+----+-------+--------+------+-----------+--------+----+-----------+--------+----+-------+--------+\n",
            "|   2 | Total other income/(expense), net | $       | (10)   |    | $       |    243 |    | (104) | %      |      | $         | (97)   |    | $         |    796 |    | (112) | %      |\n",
            "+-----+-----------------------------------+---------+--------+----+---------+--------+----+-------+--------+------+-----------+--------+----+-----------+--------+----+-------+--------+\n",
            "--------------------\n",
            "Table 3 on Page 21:\n",
            "+-----+-----------------------------------+--------+-----+----+--------+-----+----+--------+-----+----+--------+-----+\n",
            "|   0 | Effective tax rate                | 15.7   | %   |    |   10.8 | %   |    | 16.3   | %   |    |   13.8 | %   |\n",
            "+=====+===================================+========+=====+====+========+=====+====+========+=====+====+========+=====+\n",
            "|   1 | Statutory federal income tax rate | 21 %   |     |    |     21 | %   |    | 21 %   |     |    |     21 | %   |\n",
            "+-----+-----------------------------------+--------+-----+----+--------+-----+----+--------+-----+----+--------+-----+\n",
            "--------------------\n",
            "Tables found on Page 22:\n",
            "Tables found on Page 23:\n",
            "Table 1 on Page 23:\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   0 | March 27, 2022 to April 30, 2022:              |    | None    | None   | None   |   None | None   | None   | None   | None   | None   |\n",
            "+=====+================================================+====+=========+========+========+========+========+========+========+========+========+\n",
            "|   1 | Open market and privately negotiated purchases |    | 50,578  |        | $      | 168.06 |        | 50,578 |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   2 |                                                |    |         |        |        |        |        |        |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   3 | May 1, 2022 to May 28, 2022:                   |    |         |        |        |        |        |        |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   4 | Open market and privately negotiated purchases |    | 42,069  |        | $      | 148.45 |        | 42,069 |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   5 |                                                |    |         |        |        |        |        |        |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   6 | May 29, 2022 to June 25, 2022:                 |    |         |        |        |        |        |        |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   7 | Open market and privately negotiated purchases |    | 50,027  |        | $      | 139.06 |        | 50,027 |        |        |        |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "|   8 | Total                                          |    | 142,674 |        |        |        |        |        |        | $      | 85,877 |\n",
            "+-----+------------------------------------------------+----+---------+--------+--------+--------+--------+--------+--------+--------+--------+\n",
            "--------------------\n",
            "Tables found on Page 24:\n",
            "Tables found on Page 25:\n",
            "Tables found on Page 26:\n",
            "Tables found on Page 27:\n",
            "Tables found on Page 28:\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "metadata": {
        "id": "f5030939"
      },
      "source": [
        "import fitz\n",
        "import pandas as pd\n",
        "\n",
        "pdf_document = fitz.open(\"/content/drive/MyDrive/RAG/2022 Q3 AAPL.pdf\")\n",
        "extracted_data = {}\n",
        "\n",
        "for page_num in range(pdf_document.page_count):\n",
        "    page = pdf_document.load_page(page_num)\n",
        "\n",
        "    # Extract all text from the page\n",
        "    page_text = page.get_text(\"text\")\n",
        "\n",
        "    # Find tables on the page\n",
        "    tables = page.find_tables()\n",
        "\n",
        "    page_data = {\n",
        "        \"text\": page_text,\n",
        "        \"tables\": []\n",
        "    }\n",
        "\n",
        "    if tables:\n",
        "        for i, table in enumerate(tables):\n",
        "            try:\n",
        "                # Extract table data\n",
        "                table_data = table.extract()\n",
        "                # Convert to pandas DataFrame\n",
        "                df = pd.DataFrame(table_data)\n",
        "                page_data[\"tables\"].append({\n",
        "                    # \"table_number\": i + 1,\n",
        "                    # \"bbox\": table.bbox, # Store bounding box for potential context linking later\n",
        "                    \"data\": df.to_dict('records') # Store as list of dictionaries for easy saving\n",
        "                })\n",
        "            except Exception as e:\n",
        "                print(f\"Could not extract data from table {i+1} on page {page_num + 1}: {e}\")\n",
        "\n",
        "    extracted_data[f\"page_{page_num + 1}\"] = page_data\n",
        "\n",
        "pdf_document.close()\n",
        "\n",
        "# Now, extracted_data dictionary contains text and table data for each page.\n",
        "# You can inspect it or proceed to the next steps of the plan.\n",
        "# For example, to see the data from page 4:\n",
        "# print(extracted_data[\"page_4\"])"
      ],
      "execution_count": 51,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "15102f2f",
        "outputId": "3268bf4b-05bb-4a1e-f3bf-e2b24b7d7464"
      },
      "source": [
        "# Display the data extracted from page 4\n",
        "display(extracted_data[\"page_6\"])"
      ],
      "execution_count": 56,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "{'text': 'Apple Inc.\\nCONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)\\n(In millions, except number of shares which are reflected in thousands and par value)\\nJune 25,\\n2022\\nSeptember 25,\\n2021\\nASSETS:\\nCurrent assets:\\nCash and cash equivalents\\n$\\n27,502\\xa0\\n$\\n34,940\\xa0\\nMarketable securities\\n20,729\\xa0\\n27,699\\xa0\\nAccounts receivable, net\\n21,803\\xa0\\n26,278\\xa0\\nInventories\\n5,433\\xa0\\n6,580\\xa0\\nVendor non-trade receivables\\n20,439\\xa0\\n25,228\\xa0\\nOther current assets\\n16,386\\xa0\\n14,111\\xa0\\nTotal current assets\\n112,292\\xa0\\n134,836\\xa0\\nNon-current assets:\\nMarketable securities\\n131,077\\xa0\\n127,877\\xa0\\nProperty, plant and equipment, net\\n40,335\\xa0\\n39,440\\xa0\\nOther non-current assets\\n52,605\\xa0\\n48,849\\xa0\\nTotal non-current assets\\n224,017\\xa0\\n216,166\\xa0\\nTotal assets\\n$\\n336,309\\xa0\\n$\\n351,002\\xa0\\nLIABILITIES AND SHAREHOLDERS’ EQUITY:\\nCurrent liabilities:\\nAccounts payable\\n$\\n48,343\\xa0\\n$\\n54,763\\xa0\\nOther current liabilities\\n48,811\\xa0\\n47,493\\xa0\\nDeferred revenue\\n7,728\\xa0\\n7,612\\xa0\\nCommercial paper\\n10,982\\xa0\\n6,000\\xa0\\nTerm debt\\n14,009\\xa0\\n9,613\\xa0\\nTotal current liabilities\\n129,873\\xa0\\n125,481\\xa0\\nNon-current liabilities:\\nTerm debt\\n94,700\\xa0\\n109,106\\xa0\\nOther non-current liabilities\\n53,629\\xa0\\n53,325\\xa0\\nTotal non-current liabilities\\n148,329\\xa0\\n162,431\\xa0\\nTotal liabilities\\n278,202\\xa0\\n287,912\\xa0\\nCommitments and contingencies\\nShareholders’ equity:\\nCommon stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,095,378\\nand 16,426,786 shares issued and outstanding, respectively\\n62,115\\xa0\\n57,365\\xa0\\nRetained earnings\\n5,289\\xa0\\n5,562\\xa0\\nAccumulated other comprehensive income/(loss)\\n(9,297)\\n163\\xa0\\nTotal shareholders’ equity\\n58,107\\xa0\\n63,090\\xa0\\nTotal liabilities and shareholders’ equity\\n$\\n336,309\\xa0\\n$\\n351,002\\xa0\\nSee accompanying Notes to Condensed Consolidated Financial Statements.\\nApple Inc. | Q3 2022 Form 10-Q | 3\\n',\n",
              " 'tables': [{'data': [{0: 'ASSETS:',\n",
              "     1: None,\n",
              "     2: None,\n",
              "     3: None,\n",
              "     4: None,\n",
              "     5: None},\n",
              "    {0: 'Current assets:', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Cash and cash equivalents',\n",
              "     1: '$',\n",
              "     2: '27,502',\n",
              "     3: '',\n",
              "     4: '$',\n",
              "     5: '34,940'},\n",
              "    {0: 'Marketable securities',\n",
              "     1: '20,729',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '27,699',\n",
              "     5: None},\n",
              "    {0: 'Accounts receivable, net',\n",
              "     1: '21,803',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '26,278',\n",
              "     5: None},\n",
              "    {0: 'Inventories', 1: '5,433', 2: None, 3: '', 4: '6,580', 5: None},\n",
              "    {0: 'Vendor non-trade receivables',\n",
              "     1: '20,439',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '25,228',\n",
              "     5: None},\n",
              "    {0: 'Other current assets',\n",
              "     1: '16,386',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '14,111',\n",
              "     5: None},\n",
              "    {0: 'Total current assets',\n",
              "     1: '112,292',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '134,836',\n",
              "     5: None},\n",
              "    {0: '', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Non-current assets:', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Marketable securities',\n",
              "     1: '131,077',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '127,877',\n",
              "     5: None},\n",
              "    {0: 'Property, plant and equipment, net',\n",
              "     1: '40,335',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '39,440',\n",
              "     5: None},\n",
              "    {0: 'Other non-current assets',\n",
              "     1: '52,605',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '48,849',\n",
              "     5: None},\n",
              "    {0: 'Total non-current assets',\n",
              "     1: '224,017',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '216,166',\n",
              "     5: None},\n",
              "    {0: 'Total assets', 1: '$', 2: '336,309', 3: '', 4: '$', 5: '351,002'},\n",
              "    {0: '', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'LIABILITIES AND SHAREHOLDERS’ EQUITY:',\n",
              "     1: None,\n",
              "     2: None,\n",
              "     3: None,\n",
              "     4: None,\n",
              "     5: None},\n",
              "    {0: 'Current liabilities:', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Accounts payable', 1: '$', 2: '48,343', 3: '', 4: '$', 5: '54,763'},\n",
              "    {0: 'Other current liabilities',\n",
              "     1: '48,811',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '47,493',\n",
              "     5: None},\n",
              "    {0: 'Deferred revenue', 1: '7,728', 2: None, 3: '', 4: '7,612', 5: None},\n",
              "    {0: 'Commercial paper', 1: '10,982', 2: None, 3: '', 4: '6,000', 5: None},\n",
              "    {0: 'Term debt', 1: '14,009', 2: None, 3: '', 4: '9,613', 5: None},\n",
              "    {0: 'Total current liabilities',\n",
              "     1: '129,873',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '125,481',\n",
              "     5: None},\n",
              "    {0: '', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Non-current liabilities:', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Term debt', 1: '94,700', 2: None, 3: '', 4: '109,106', 5: None},\n",
              "    {0: 'Other non-current liabilities',\n",
              "     1: '53,629',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '53,325',\n",
              "     5: None},\n",
              "    {0: 'Total non-current liabilities',\n",
              "     1: '148,329',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '162,431',\n",
              "     5: None},\n",
              "    {0: 'Total liabilities',\n",
              "     1: '278,202',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '287,912',\n",
              "     5: None},\n",
              "    {0: '', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Commitments and contingencies',\n",
              "     1: '',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '',\n",
              "     5: None},\n",
              "    {0: '', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Shareholders’ equity:', 1: '', 2: None, 3: '', 4: '', 5: None},\n",
              "    {0: 'Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 16,095,378\\nand 16,426,786 shares issued and outstanding, respectively',\n",
              "     1: '62,115',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '57,365',\n",
              "     5: None},\n",
              "    {0: 'Retained earnings', 1: '5,289', 2: None, 3: '', 4: '5,562', 5: None},\n",
              "    {0: 'Accumulated other comprehensive income/(loss)',\n",
              "     1: '(9,297)',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '163',\n",
              "     5: None},\n",
              "    {0: 'Total shareholders’ equity',\n",
              "     1: '58,107',\n",
              "     2: None,\n",
              "     3: '',\n",
              "     4: '63,090',\n",
              "     5: None},\n",
              "    {0: 'Total liabilities and shareholders’ equity',\n",
              "     1: '$',\n",
              "     2: '336,309',\n",
              "     3: '',\n",
              "     4: '$',\n",
              "     5: '351,002'}]}]}"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "\n",
        "# Define the path where you want to save the JSON file\n",
        "output_json_path = \"/content/drive/MyDrive/RAG/extracted_pdf_data.json\"\n",
        "\n",
        "# Save the extracted_data dictionary to a JSON file\n",
        "with open(output_json_path, 'w') as f:\n",
        "    json.dump(extracted_data, f, indent=4)\n",
        "\n",
        "print(f\"Extracted data saved to {output_json_path}\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "WLwTBeXlr0Ns",
        "outputId": "63b96bc1-c788-4ed1-a870-60122a997b70"
      },
      "execution_count": 58,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Extracted data saved to /content/drive/MyDrive/RAG/extracted_pdf_data.json\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# **load json and display sample final data**"
      ],
      "metadata": {
        "id": "RbQFAbQVt0gn"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "import json\n",
        "\n",
        "# Define the path to the saved JSON file\n",
        "output_json_path = \"/content/drive/MyDrive/RAG/extracted_pdf_data.json\"\n",
        "\n",
        "# Load the data from the JSON file\n",
        "with open(output_json_path, 'r') as f:\n",
        "    loaded_data = json.load(f)\n",
        "\n",
        "display(loaded_data[\"page_2\"])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 104
        },
        "id": "wBg4IIckt3kx",
        "outputId": "ee4ba4bd-c249-478c-f494-0b1c1e4f0ddb"
      },
      "execution_count": 61,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "{'text': 'If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial\\naccounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\\nIndicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).\\nYes\\xa0\\xa0☐\\xa0\\xa0\\xa0\\xa0\\xa0No\\xa0\\xa0☒\\n16,070,752,000 shares of common stock were issued and outstanding as of July\\xa015, 2022.\\n',\n",
              " 'tables': []}"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "display(loaded_data[\"page_8\"])"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 798
        },
        "id": "4Ddjmj6euMid",
        "outputId": "55d2222b-e7e4-4067-e278-907ac6ab3c01"
      },
      "execution_count": 65,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "{'text': 'Apple Inc.\\nCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)\\n(In millions)\\nNine Months Ended\\nJune 25,\\n2022\\nJune 26,\\n2021\\nCash, cash equivalents and restricted cash, beginning balances\\n$\\n35,929\\xa0\\n$\\n39,789\\xa0\\nOperating activities:\\nNet income\\n79,082\\xa0\\n74,129\\xa0\\nAdjustments to reconcile net income to cash generated by operating activities:\\nDepreciation and amortization\\n8,239\\xa0\\n8,295\\xa0\\nShare-based compensation expense\\n6,760\\xa0\\n5,961\\xa0\\nDeferred income tax expense/(benefit)\\n2,756\\xa0\\n(737)\\nOther\\n(61)\\n(689)\\nChanges in operating assets and liabilities:\\nAccounts receivable, net\\n4,561\\xa0\\n(1,316)\\nInventories\\n1,049\\xa0\\n(1,213)\\nVendor non-trade receivables\\n4,789\\xa0\\n4,892\\xa0\\nOther current and non-current assets\\n(3,289)\\n(5,899)\\nAccounts payable\\n(6,108)\\n(1,786)\\nDeferred revenue\\n260\\xa0\\n1,738\\xa0\\nOther current and non-current liabilities\\n(14)\\n463\\xa0\\nCash generated by operating activities\\n98,024\\xa0\\n83,838\\xa0\\nInvesting activities:\\nPurchases of marketable securities\\n(70,178)\\n(94,052)\\nProceeds from maturities of marketable securities\\n24,203\\xa0\\n49,880\\xa0\\nProceeds from sales of marketable securities\\n33,609\\xa0\\n36,745\\xa0\\nPayments for acquisition of property, plant and equipment\\n(7,419)\\n(7,862)\\nPayments made in connection with business acquisitions, net\\n(169)\\n(13)\\nOther\\n(1,183)\\n(78)\\nCash used in investing activities\\n(21,137)\\n(15,380)\\nFinancing activities:\\nPayments for taxes related to net share settlement of equity awards\\n(5,915)\\n(5,855)\\nPayments for dividends and dividend equivalents\\n(11,138)\\n(10,827)\\nRepurchases of common stock\\n(64,974)\\n(66,223)\\nProceeds from issuance of term debt, net\\n—\\xa0\\n13,923\\xa0\\nRepayments of term debt\\n(6,750)\\n(7,500)\\nProceeds from commercial paper, net\\n4,970\\xa0\\n3,022\\xa0\\nOther\\n(148)\\n489\\xa0\\nCash used in financing activities\\n(83,955)\\n(72,971)\\nDecrease in cash, cash equivalents and restricted cash\\n(7,068)\\n(4,513)\\nCash, cash equivalents and restricted cash, ending balances\\n$\\n28,861\\xa0\\n$\\n35,276\\xa0\\nSupplemental cash flow disclosure:\\nCash paid for income taxes, net\\n$\\n12,251\\xa0\\n$\\n18,536\\xa0\\nCash paid for interest\\n$\\n1,910\\xa0\\n$\\n1,870\\xa0\\nSee accompanying Notes to Condensed Consolidated Financial Statements.\\nApple Inc. | Q3 2022 Form 10-Q | 5\\n', 'tables': [{'data': [{'0': 'Operating activities:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Net income', '1': '79,082', '2': None, '3': '', '4': '74,129', '5': None}, {'0': 'Adjustments to reconcile net income to cash generated by operating activities:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Depreciation and amortization', '1': '8,239', '2': None, '3': '', '4': '8,295', '5': None}, {'0': 'Share-based compensation expense', '1': '6,760', '2': None, '3': '', '4': '5,961', '5': None}, {'0': 'Deferred income tax expense/(benefit)', '1': '2,756', '2': None, '3': '', '4': '(737)', '5': None}, {'0': 'Other', '1': '(61)', '2': None, '3': '', '4': '(689)', '5': None}, {'0': 'Changes in operating assets and liabilities:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Accounts receivable, net', '1': '4,561', '2': None, '3': '', '4': '(1,316)', '5': None}, {'0': 'Inventories', '1': '1,049', '2': None, '3': '', '4': '(1,213)', '5': None}, {'0': 'Vendor non-trade receivables', '1': '4,789', '2': None, '3': '', '4': '4,892', '5': None}, {'0': 'Other current and non-current assets', '1': '(3,289)', '2': None, '3': '', '4': '(5,899)', '5': None}, {'0': 'Accounts payable', '1': '(6,108)', '2': None, '3': '', '4': '(1,786)', '5': None}, {'0': 'Deferred revenue', '1': '260', '2': None, '3': '', '4': '1,738', '5': None}, {'0': 'Other current and non-current liabilities', '1': '(14)', '2': None, '3': '', '4': '463', '5': None}, {'0': 'Cash generated by operating activities', '1': '98,024', '2': None, '3': '', '4': '83,838', '5': None}, {'0': 'Investing activities:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Purchases of marketable securities', '1': '(70,178)', '2': None, '3': '', '4': '(94,052)', '5': None}, {'0': 'Proceeds from maturities of marketable securities', '1': '24,203', '2': None, '3': '', '4': '49,880', '5': None}, {'0': 'Proceeds from sales of marketable securities', '1': '33,609', '2': None, '3': '', '4': '36,745', '5': None}, {'0': 'Payments for acquisition of property, plant and equipment', '1': '(7,419)', '2': None, '3': '', '4': '(7,862)', '5': None}, {'0': 'Payments made in connection with business acquisitions, net', '1': '(169)', '2': None, '3': '', '4': '(13)', '5': None}, {'0': 'Other', '1': '(1,183)', '2': None, '3': '', '4': '(78)', '5': None}, {'0': 'Cash used in investing activities', '1': '(21,137)', '2': None, '3': '', '4': '(15,380)', '5': None}, {'0': 'Financing activities:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Payments for taxes related to net share settlement of equity awards', '1': '(5,915)', '2': None, '3': '', '4': '(5,855)', '5': None}, {'0': 'Payments for dividends and dividend equivalents', '1': '(11,138)', '2': None, '3': '', '4': '(10,827)', '5': None}, {'0': 'Repurchases of common stock', '1': '(64,974)', '2': None, '3': '', '4': '(66,223)', '5': None}, {'0': 'Proceeds from issuance of term debt, net', '1': '—', '2': None, '3': '', '4': '13,923', '5': None}, {'0': 'Repayments of term debt', '1': '(6,750)', '2': None, '3': '', '4': '(7,500)', '5': None}, {'0': 'Proceeds from commercial paper, net', '1': '4,970', '2': None, '3': '', '4': '3,022', '5': None}, {'0': 'Other', '1': '(148)', '2': None, '3': '', '4': '489', '5': None}, {'0': 'Cash used in financing activities', '1': '(83,955)', '2': None, '3': '', '4': '(72,971)', '5': None}, {'0': 'Decrease in cash, cash equivalents and restricted cash', '1': '(7,068)', '2': None, '3': '', '4': '(4,513)', '5': None}, {'0': 'Cash, cash equivalents and restricted cash, ending balances', '1': '$', '2': '28,861', '3': '', '4': '$', '5': '35,276'}, {'0': 'Supplemental cash flow disclosure:', '1': '', '2': None, '3': '', '4': '', '5': None}, {'0': 'Cash paid for income taxes, net', '1': '$', '2': '12,251', '3': '', '4': '$', '5': '18,536'}, {'0': 'Cash paid for interest', '1': '$', '2': '1,910', '3': '', '4': '$', '5': '1,870'}]}]}"
            ]
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "gBrPxmA_uVtv"
      },
      "execution_count": null,
      "outputs": []
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.6.8"
    },
    "colab": {
      "provenance": []
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}